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ABSTRACT 
Cunge Zheng 
 
THE EFFECT OF CIGARETTE SMOKING ON THE VIRULENCE OF 
STREPTOCOCCUS MUTANS CARIES AND CARDIOVASCULAR DISEASE-
EPIDEMIOLOGICAL ANALYSIS AND IN VITRO STUDIES 
 
The impact of tobacco smoking on human health is well documented. The influence of 
smoking on tooth loss and cardiovascular diseases was investigated in the current study 
via both epidemiology and in vitro studies.   
 
From analyzing the 2006 Behavioral Risk Factor Surveillance System (2006 BRFSS) 
database, we confirmed that smoking was significantly associated with the number of 
teeth lost in a dose-dependent manner and smoking cessation reduced the risk when 
compared to those subjects continuing to smoke. In addition, the virulence factors related 
to caries were compared between Streptococcus mutans and Streptococcus gordonii in 
response to cigarette smoking condensate (CSC) treatment.  We observed that S. gordonii 
was more susceptible to CSC treatment than S. mutans. CSC significantly enhanced S. 
mutans sucrose-dependent and independent adherence. Western blot assays revealed that 
several bacterial surface proteins including glucosyltransferase (GTF), glucan-binding 
proteins and antigen I/II, were significantly upregulated for the treated S. mutans. These 
findings suggested that the oral environment with CSC may favor a cariogenic dominant 
composition, which may increase the risk for smokers to develop caries.  
vi 
 
We also found that smoking and oral health status modified each other and synergistically 
increased the risk of CVD and this joint effect was more pronounced among the youngest 
age group using the 2006 BRFSS database. To further understand the joint effect, we 
conducted an in vitro study to investigate bacterial attachment to fibronectin and 
endothelial cells in response to smoking condensate treatment. Our study clearly 
demonstrated CSC significantly enhanced S. mutans attachment to both soluble and 
immobilized fibronectin as well as endothelial cells. Furthermore, our data suggested that 
bacteria possessed several adhesins that bound to host tissues and endothelial cells also 
had multiple receptors for bacterial attachment. Among these adhesins, antigen I/II 
seemed essential for bacterial attachment to endothelial cells without CSC. The 
knowledge of bacterial attachment to host tissues in the presence of CSC may help in 
developing different preventive or therapeutic strategies against attachment and 
colonization of the host by S. mutans.  
Richard L. Gregory, Ph.D., Chair 
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1 
SPECIFIC AIMS 
The impact of tobacco smoking on human health is well documented. The most often 
mentioned systemic diseases related to smoking are lung cancer and cardiovascular 
diseases. However, since the components of cigarette smoke contact the oral cavity first, 
the influence of smoking on oral health status should not be neglected. Smoking has been 
linked to tooth loss, but there is no conclusive research about what the biological 
mechanisms are underlying this relationship.  
 
Both cigarette smoking and oral health status are risk factors for CVD. It is implicated 
that if the individual has multiple risk factors, these risk factors have combined effect on 
CVD. There is no such research to investigate the joint effect of smoking and oral health 
status on CVD. Also, it is unknown what biological mechanisms are responsible for this 
joint effect, if they exist.  
 
In this study, we applied epidemiological methods to detect the effect of smoking on the 
number of teeth lost and the joint effect of smoking status and oral health status on CVD. 
Then, we used laboratory techniques to investigate what biological mechanisms 
contributed to these relationships focusing on bacterial attachment. Therefore, it was 
hypothesized that smokers were at higher risk of having more teeth removed due to caries 
and periodontal diseases and the risk of developing CVD for individuals who are 
smoking and have severe oral health status (using tooth loss as an indicator) at the same 
2 
time would be greater than the combination of risks of smoking and a poor oral health 
status. As for the biological mechanisms, it was hypothesized that smoking enhances 
bacterial attachment to host tissues including dental hard tissue, fibronectin and 
endothelial cells.  
 
The project included the following specific aims: 
1) To analyze the relationship between smoking and the number of teeth removed due 
to caries and periodontal diseases from the 2006 Behavioral Risk Factor Surveillance 
System (2006 BRFSS) database.  
2) To investigate the virulence factors of S. mutans in response to cigarette smoke 
condensate (CSC) treatment by comparing the growth and sucrose-dependent adherence 
of S. mutans and S. gordonii treated with CSC, as well as sucrose-independent adherence 
and acid generation of the treated and untreated S. mutans. 
3) To detect the joint effect of smoking and the number of teeth removed on CVD from 
the 2006 BRFSS database.  
4) To study the S. mutans attachment to fibronectin (Fn) and endothelial cells in 
response to CSC treatment and define the roles of antigen I/II in bacterial attachment with 
or without CSC treatment.   
3 
BACKGROUND 
1. Smoking and dental caries 
1.1 The microbial etiology of dental caries 
Dental caries is one of the most prevalent infectious diseases in our society and occurs in 
all populations with different severity. It is a progressive demineralization process of the 
dental hard tissues and is caused by the bacteria in dental plaque such as mutans 
streptococci and lactobacilli, which are able to ferment dietary carbohydrates to produce 
acid.  
 
1.1.1 Three dental plaque hypotheses related to dental caries 
Bacteria are the essential component in caries development. However, the precise roles of 
these diverse bacterial species in dental decay are not clear. There are three hypotheses 
concerning these bacterial plaque components. The non-specific plaque hypothesis 
proposed that the entire microbial community of plaque that accumulates on tooth 
surfaces contributes to the development of dental caries (132). Dental plaque control such 
as toothbrushing is an effective preventive method. While the specific plaque hypothesis 
states that among the diverse collection of bacteria in dental plaque, only a few species 
are involved in caries development (133-134). That is, dental caries is caused by the 
presence of specific bacteria like MS and LB other than the plaque per se. These specific 
pathogens can be targeted with specific anti-caries treatment and prophylactic strategies.  
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With advanced technologies such as confocal microscopy, dental plaque is now regarded 
as a structurally and functionally organized biofilm (144-145). The new ecological plaque 
hypothesis of dental plaque suggests that the diverse microorganisms embedded in a 
matrix of polymers are the constituents of one dynamic community. Although mature 
dental plaque is relative stable in terms of the composition of complex resident organisms, 
a substantial change in one factor that is required for ecological stability may break down 
this microbial homeostasis. This breakdown will result in the outgrowth of previously 
minor bacterial components and ultimately cause dental caries in the mouth (143). Thus, 
the factors that increase cariogenic bacterial growth and competency to neighboring cells 
and/or enhance cariogenic bacteria adhesion and colonization will switch a 
non-cariogenic community to a cariogenic community.   
 
1.1.2 Bacterial attachment 
It is well known that dental decay is closely related to dental plaque. There are several 
distinct stages associated with dental plaque formation (143). Firstly, acquired pellicle is 
formed on the tooth surface. Secondly, the reversible attachment of bacterial cells to the 
pellicle is through weak long-range physico-chemical interactions. Thirdly, secondary 
colonizers bind to already attached cells. Finally, with the synthesis of 
exopolysaccharides, bacteria attach to tooth surfaces firmly to form dental biofilm, and 
occasionally some bacteria might detach from the tooth surface.  
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S. mutans has been identified as the primary etiologic bacterium of dental caries since 
1960 (133). The important steps of S. mutans involved in dental plaque formation include 
initial sucrose-independent attachment based on the function of antigen I/II and 
sucrose-dependent attachment involving several glucan-binding proteins. 
 
Sucrose-independent adherence  
In the absence of sucrose, S. mutans can adhere to salivary components via cell 
wall-associated antigen I/II (also known as P1, SpaP, PAc, and antigen B). Antigen I/II is 
produced by most oral viridans streptococci and is highly conserved among different 
species with a molecular weight between 180 kDa and 210 kDa. Antigen I/II family 
polypeptides from 6 species of oral streptococci are encoded by 14 genes and consist of 
1310-1653 amino acid (aa) residues (96). Currently, all strains of S. mutans tested express 
only one gene of antigen I/II, which can be divided into two groups-spaP in S. mutans 
NG5 (108) and pac in S. mutans MT8148, based on restriction fragment length 
polymorphism (RFLP) analyses (169). Two antigen I/II family peptides-SspA (172 kDa) 
and SspB (164 kDa), are expressed by S. gordonii DL1 (Challis) (49). 
 
These proteins share a highly conserved sequence structure, which can be divided into 
seven distinct regions (Figure 1): (1) a signal peptide (38 residues, directing protein 
export via the general secretion pathway); (2) an N-terminal leader peptide (about 80 
residues) ; (3) an alanine-rich repeat domain (A-region, about 320 residues containing 
6 
one to four copies of 82-residue repeats); (4) a variable region (V-region, residues 
457-843, presenting some variability among the antigen I/II family and 
carbohydrate-binding (lectin-like) domain); (5) a proline-rich repeat domain (P-region, 
about 180 residues containing three 39 residue repeats); (6) a C-terminal domain (about 
615 residues); and (7) a cell-wall-anchoring motif (LPXTG motif, resulting in covalent 
linkage of the polypeptide to cell wall peptidoglycan) (125, 213). The polypeptides of 
SpaP and PAc produced by different S. mutans strains are 97% identical with the major 
differences in the V region involving 26 aa residue changes (124). The two different 
antigen I/II polypeptides-SspA and SspB proteins expressed by the same S. gordonii 
strains have more than 96% identical aa residues in the N-terminal and C-terminal 
regions, but share only 26% of identity in their V regions (49).  
 
Antigen I/II is a multifunctional protein. The roles of antigen I/II in non-sucrose mediated 
adherence were investigated using isogenic mutants of oral streptococci deficient in 
antigen I/II (114, 126). In these studies, the antigen I/II-negative mutants displayed much 
less hydrophobicity, less aggregation with clarified whole saliva or a 
high-molecular-weight salivary agglutinin and less adherence to agglutinin-coated 
hydroxyapatite. 
 
The major receptor for antigen I/II is highly glycosylated salivary agglutinin glycoprotein 
(SAG, also known as gp340), which is a member of the scavenger receptor cysteine-rich 
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family of secreted host proteins (126). The other receptors for antigen I/II include type I 
collagen (136), fibronectin, fibrinogen (22), other species of oral bacteria such as 
Actinomyces naeslundii (86) and host cells such as epithelial cells (94).   
 
SAG has a fluid phase and a solid surface phase and antigen I/II is able to interact with 
both of them (10). The fluid phase of this protein is involved in the clumping and 
clearance of microbial cells from oral cavity, as well as aggregation of other 
gram-positive and gram-negative bacteria. But, when the SAG protein is immobilized on 
solid surfaces like teeth or epithelium, it can be regarded as a receptor for bacterial 
adhesion.  
 
The interaction of antigen I/II of S. mutans with SAG plays an important role in dental 
caries development. It is known that S. mutans is able to aggregate in the presence of 
human whole saliva or salivary agglutinin. Isogenic mutants of S. mutans deficient in 
antigen I/II failed to aggregate with whole saliva or salivary agglutinin (126). The solid 
phase salivary agglutinin that is adsorbed on dental hard tissue (acquired pellicle) 
provides the initial adhesion sites for S. mutans. Therefore, antigen I/II is important for 
the initial attachment of S. mutans to tooth surface.  
 
The biofilm formed by the wild-type S. mutans and isogenic antigen I/II-deficient mutant 
were compared (177). The level of biofilm formed by the mutant strain with saliva was 
8 
65% less than that by the wild-type. However, without saliva, no difference was found. 
Besides under static conditions, antigen I/II is able to enhance bacterial adhesion to saliva 
conditioned surfaces under flowing situations. When the binding ability of wild-type S. 
mutans and their isogenic antigen I/II-deficient mutants to saliva coated glass was 
compared under a flowing situation, the final attached mutant cells was reduced by 90% 
(178).   
 
The cariogenicity of S. mutans was also compared between the wild-type and antigen 
I/II-negative mutant strains in a gnotobiotic rat model using a diet containing 5% sucrose 
(39). After a 6-week infection, carious lesions were scored. The mutant-infected rats had 
a significantly lower number of enamel and dentinal carious lesions than the rats infected 
with the wild-type S. mutans. Thus, the decreasing cariogenicity of S. mutans lacking 
antigen I/II proteins on the bacterial surface documented the important role of antigen I/II 
in the virulence of S. mutans associated with dental caries development.  
 
Sucrose-dependent attachment 
Glucosyltransferases  
Another most important cariogenic factors of S. mutans is its sucrose-dependent 
adherence, in which the organisms hydrolyze sucrose into fructose and glucose and 
polymerize glucose into glucan via glucosyltransferases (GTFs), then firmly attach to the 
tooth surface through the interaction of the glucans with GTFs and other glucan binding 
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proteins. Therefore, S. mutans has been considered as a key contributor to the formation 
of extracellular polysaccharide matrix in dental biofilms. 
 
Three types of GTFs are produced by S. mutans-GTFB, GTFC and GTFD (19). GTFB 
associated with bacterial surfaces mainly synthesize water-insoluble glucans rich in 
α-1,3-glucosidic linkages, while GTFD released into the culture supernatant only 
synthesizes water-soluble glucans rich in α-1,6-glucosidic linkages. GTFC can produce 
both soluble and insoluble-glucans. In contrast, S. gordonii has only one GTF enzyme 
which synthesizes both water soluble and insoluble-glucans (19).  
 
The streptococcal GTF enzymes possess highly homologous primary amino acid 
sequences. GTFs of S. mutans with molecular weights between 150 to 155 kDa have two 
distinct functional domains-the catalytic and glucan-binding domains. The catalytic 
domain at the N-terminal region is responsible for sucrose hydrolysis (157), and the 
glucan-binding domain at one-third of the carboxyl-terminal region contributes to 
bacterial attachment (5). The conserved amino acids repeats within the C-terminal have 
been defined in various length: such as 33-aa „A‟, 48-aa „B‟, 20-aa „C‟, and 14-aa „D‟ 
repeats (19). The „A‟ repeat is shared by all streptococcal GTF enzymes and 
glucan-binding protein A (18). However, these repeats have not been linked to any 
functional activities of GTFs.   
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All of these GTFs play significant roles in the synthesis of adhesive and insoluble glucans 
from sucrose [20]. Moreover, it was also indicated that the three GTF expressed by S. 
mutans at the ratio of 20 GTFB: 1 GTFC: 4 GTFD may be necessary for the highest level 
of sucrose-dependent adherence. 
 
Recently, Koo et al. reported that there were considerably fewer microcolonies formed on 
saliva-coated hydroxyapatite surfaces by S. mutans strains defective in gtfB or gtfB/gtfC 
genes (117). It was further indicated that both gtfB and gtfC genes are required for 
sucrose-dependent colonization by S. mutans in the presence of S. oralis and Actinomyces 
naeslundii. Therefore, GTFs are important for S. mutans to become the major species in 
the mature multi-species biofilm.  
 
Glucan-binding proteins 
Four glucan-binding proteins (Gbps) expressed by S. mutans have been reported: GbpA, 
GbpB GbpC, and GbpD, which are encoded by genes gbpA, gbpB, gbpC, and gbpD, 
respectively (19). The loss of any of the Gbps may influence bacterial adherence and 
biofilm structure.  
 
Russell (187) first isolated three glucan-binding proteins from S. mutans serotype c. It 
was observed that glucans containing 1,3-alpha or 1,6-alpha bonds were attached to these 
proteins and two of these proteins might affect the activity of glucosyltransferase. Then, 
11 
the structural gene for one of the Gbps designated GbpA was successfully inserted into E. 
coli and expressed a protein with the same size as the 74 kDa protein of S. mutans (188). 
The C-terminal glucan-binding domain of GbpA is believed to have a high percentage of 
beta-sheets, which are able to form a hydrophobic core and facilitate binding to both 
water soluble and insoluble-glucan (19). 
 
GbpB is distinct from GbpA in terms of molecular weight, elution position in a salt 
gradient, and antigenicity (197). GbpB with a molecular mass of 59 kDa is detectable in 
culture supernatants of all laboratory strains of S. mutans and can elicit significant levels 
of salivary IgA antibody in humans. The third Gbp named as GbpC is a cell surface 
associated protein with membrane anchor and cell-wall-binding sites (191). GbpC is 
related to the PAc family of streptococcal proteins and associated with the 
glucan-dependent aggregation.  
 
By searching in the S. mutans genome sequence for open reading frames containing 'A' 
repeats, which is a binding domain already found in GTF and GbpA, Shah and Russell 
(193) found another novel gene, gbpD encoding GbpD. The wild-type strains were more 
hydrophobic than their isogenic GbpD mutants. It was also found that the ability of 
aggregation induced by polymers derived from sucrose was altered in GbpD deficient 
mutants.  
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Although the biological significance of the Gbps is not fully understood, accumulating 
evidence support the hyppothesis that these proteins play a role in maintaining biofilm 
architecture by connecting bacteria to extracellular molecules of glucan and are important 
for bacterial virulence. The biofilm formed by isogenic GbpA- and GbpC-defective 
mutants was significantly less than that of their parent strain MT8148 (148). Moreover, 
rats infected with these defective mutants also developed fewer carious lesions than rats 
infected with the wild type strain. It was indicated that GbpA and GbpC participate in 
bacterial adherence to tooth surfaces and contribute to the cariogenic virulence of S. 
mutans. Furthermore, GbpC protein was demonstrated to bind to the glucan synthesized 
by GTFD more than the glucan synthesized by either GTFB or GTFC (147). Thus, it was 
implied that the important role of GbpC in sucrose-dependent adhesion is due to binding 
to the soluble glucan synthesized by GTFD. The biofilms formed by S. mutans strains 
lacking GbpA, GbpC or GbpD were analyzed using confocal microscopy and quantified 
by the biofilm quantification software comstat (139). The mutant strains formed thinner 
biofilms than the parent strain, and the depth reduction depended on which particular Gbp 
was missing. It was further suggested that GbpC is the principal receptor for glucan and 
the lack of either GbpA or GbpD also remarkably altered the biofilm structure in a unique 
manner.  
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1.1.3 Acid production 
There is a continuous change in salivary pH after consumption of fermentable 
carbohydrate-containing food (200). It is believed that the reduction of pH in dental 
plaque to a certain or critical level could cause demineralization of the dental enamel. 
Therefore, dental caries has been considered as a pH-mediated disease. S. mutans are able 
to produce lactate, formate, acetate and ethanol as fermentation products via a complete 
glycolytic pathway (11). The ability of S. mutans to produce acid varies among strains 
isolated from different individuals with varying caries experience (45, 115). The 
acidogenicity of S. mutans may cause ecological alterations of resident microbes in dental 
plaque including outgrowth of S. mutans and other acidogenic and acid-tolerant species 
(16). Once plaque pH is lower than the critical pH around 5.4, the balance between 
remineralization and demineralization is broken down and mineral dissolution would 
become dominant until the pH value rises above the critical pH again.   
 
1.2 Smoking and tooth loss-Epidemiological evidence   
Data from the National Health and Nutrition Examination Survey (NHANES) from 
1988-1994 and 1999-2002 suggested a 6% reduction in total tooth loss (edentulism) 
among persons aged more than 60 years in United States (25). However, health 
disparities still remain among subgroups of the population. In a longitudinal analysis of 
national data of the first NHANES of 1971-84, the incidence of edentulism was 
correlated with lower income and education status, poor oral health, self-perceptions of 
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poor general health and oral health, absence of a regular dentist, and a lower number of 
remaining teeth at baseline (58). 
 
The impact of tobacco smoking on human health is well documented. The most often 
mentioned systemic diseases related to smoking are lung cancer and cardiovascular 
diseases (80). However, since the components of cigarette smoke contact the oral cavity 
first, the influence of smoking on oral health status should not be neglected. The noxious 
effects of smoking on the oral cavity may vary from serious diseases like oral cancer and 
periodontal disease to mild outcomes like tar staining on tooth surfaces and dental 
restorations (230). For example, tobacco has been regarded as an independent risk factor 
for oral cancer and the risk for smokers is 7-10 times higher than for non-smokers (223). 
Smoking has also been linked to tooth loss independent of age, education, 
socio-economic status, frequency of tooth brushing, and frequency of visits to a dentist in 
many studies (9, 14, 168).  
 
The correlation between dental status with respect to periodontal diseases, caries and 
edentulousness with smoking habits was examined in randomized samples of 35-, 50-, 
65-, and 75-year-old subjects (14). In all age groups, smokers had a higher number of 
missing surfaces, lower number of remaining teeth and larger mean probing attachment 
loss than non-smokers, although the smokers and non-smokers had similar plaque index 
15 
and oral hygiene. It was indicated that smoking is a significant risk indicator for tooth 
loss, probing attachment loss and dental caries. 
 
In a longitudinal population study in Sweden, the differences in the number of teeth lost 
between female smokers and non-smokers were compared after a 12-year observation (9). 
During this period, the mean number of teeth lost was 3.5 among smokers and 2.1 among 
non-smokers, which was over 60% higher among smokers than among non-smokers.  
 
The association between cigarette smoking and tooth loss was also investigated among 
young adults aged 20-39 years in Japan using linked data from the two national databases 
(168). Among this Asian population, current smoking was significantly associated with 
1+ tooth loss in both men and women with the adjusted odds ratio (OR) of 2.21 and 1.70, 
respectively. In another follow-up study in USA, the younger smokers who smoked more 
than 15 cigarettes per day were found to have as high as 4.5 times the risk of tooth loss 
during a 10-year observation period (85). This study suggested that smokers, especially 
those less than 50 years old, might be a high risk group for tooth loss. 
 
1.3 Smoking and caries-Epidemiological evidence  
Dental caries and periodontal diseases are the most common oral health problems around 
the world and ultimately may cause tooth loss. From the 3
rd
 NHANES, 80% of total 
periodontal diseases were attributable to current or former smoking (210). Furthermore, a 
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causal relationship between smoking and periodontal diseases has been established (1). 
Therefore, cigarette smoking has been considered the most important preventable risk 
factor for periodontal diseases. However, since both periodontal diseases and caries 
contribute to tooth extraction and many studies have demonstrated that dental caries is 
still the principal cause for tooth extraction which is responsible for up to 58% of teeth 
removed (35, 190, 194, 209, 215), the effect of smoking on dental caries should not be 
neglected. And for our interest, the relationship between smoking and dental caries will 
be discussed from the epidemiological and biological viewpoints.  
 
Although caries prevalence in the U.S. decreased between 1988 and 1994 according to 
the NHANES, there are still approximately 91% of adults aged >20 years who 
experienced caries (25). Moreover, there are numerous reports on the relationship 
between smoking and prevalence of caries (8, 14, 168, 196, 211).  
 
From a cross-sectional study among randomized samples of 35, 50, 65, and 75-year old 
subjects in Sweden, it was found that smoking was a significant independent risk factor 
for caries in all age groups (14). For example, the 50, 65, and 75-year old smokers had 
more missing tooth surfaces than non-smokers, and the 35-year old smokers had larger 
numbers of decayed and filled tooth surfaces. The plaque indices and oral hygiene were 
similar in smokers and non-smokers.  
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In another recent survey of Mexican truck drivers, caries status was significantly related 
to tobacco smoking exposure in a dose-dependent manner (8). In this study, the 
prevalence of “large” cavities increased from 14.6 to 33.3% when the cigarette 
consumption increased from 1-3 cigarettes/day to >10 cigarettes/day.  
 
The positive association of cigarette smoking and prevalence of decayed teeth was also 
found among a young population in Japan (168). The association was significant in both 
genders with the adjusted ORs of 1.87 and 1.56 for male and female, respectively.  
 
Furthermore, environmental tobacco smoke (ETS) was also linked to caries development 
among children (13, 204). For example, it was found that not only maternal smoking 
during pregnancy but also postnatal ETS exposure was a risk factor for caries among 
2,015 Japanese children around 3 years old (13). In another study in Turkey, children 
exposed to ETS had significantly greater dmft (Decayed, Missing & Filled teeth) scores 
and higher numbers of cariogenic bacteria (S. mutans and lactobacilli) in saliva than 
control subjects with similar oral health habits and social economic status (204).  
 
1.4 Smoking and caries-Biological mechanisms  
Although the relationship between caries and smoking has been documented in many 
epidemiological investigations, very few studies have focused on the biological 
mechanisms of why smokers or children exposed to environmental tobacco smoking are 
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prone to caries development. It is well accepted that caries, as an infectious disease, is the 
result of a complex interaction between oral bacteria (cariogenic and non-cariogenic 
bacteria), oral environment (like diet and smoking) and host (such as salivary function 
and immune response).  
 
Saliva is an important protective factor based on its buffer capacity, diluting and 
eliminating sugars and other substances, balancing demineralization/remineralization and 
antimicrobial action (131). Thus, both quantity and quality of saliva can significantly 
influence an individual‟s caries risk. 
 
The buffering capacity of saliva, which mainly depends on salivary components like 
proteins, bicarbonate and phosphate would raise the pH from acidic to normal and 
remineralize dental enamel (203). The buffering capacity of saliva is also related to 
salivary flow rate. When the normal quantity of saliva is reduced in patients with salivary 
disorders such as hyposalivation or hypoptyalism, the risk of developing caries, 
especially in atypical locations, will be increased (43). Besides age and gender, many 
other factors such as smoking and alcohol consumption have been proposed to affect 
salivary flow rate and its buffering capacity.  
 
Typically, it has been observed that smoking does not affect salivary flow rate, but might 
impair its buffering capacity (175, 214, 228). Salivary flow rate and bicarbonate 
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concentrations were measured before and after smoking cessation in healthy subjects 
(214). There was no significant correlation between smoking status and salivary flow. 
However, smoking cessation after one week significantly increased salivary bicarbonate 
secretion. Fenoll-Palomares et al. (62) also investigated the relationship between the 
salivary flow rate, pH, and buffering capacity and smoking status among another 
population of healthy volunteers (age >18 years, absence of medical conditions that could 
decrease salivary flow). It was found that the salivary parameters of these healthy 
subjects were affected only by gender and age other than smoking or alcohol 
consumption. 
 
The role of immunoglobulin (Ig) in caries protection against certain pathogens has been 
established (186). Secretory immunity in defense against cariogenic bacteria is mainly 
provided by salivary secretory IgA (sIgA) antibodies. sIgA is generated by the common 
mucosal immune system. These antibodies could interfere with bacterial sucrose 
dependent and independent adherence and possibly inhibit bacterial metabolic activities. 
Specific IgA antibodies are secreted by IgA-producing plasma cells as an IgA-J 
chain-IgA polymer. Secretory epithelial cells in proximity to plasma cells are responsible 
for producing other secretory products including secretory component, lactoferrin and 
lysozyme (118). 
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It is known that cigarette smoking noticeably impacts the host immune system to promote 
infection, lung diseases and cancer (199). As for dental caries, Gregory et al. (72-74) 
reported that smokeless tobacco users had significantly higher levels of immunoglobulin 
A and J chain, but lower levels of secretory component, lactoferrin, and lysozyme levels 
in whole saliva than in non-tobacco users, which indicated that smokers have impaired 
immune responses. 
 
In theory, cigarette smoking may not only induce physiological changes and/or impair 
immune function of the host, but also be able to enhance the virulence of pathogens (61). 
Parvinen reported that the proportions of high lactobacillus counts significantly increased 
among smokers (175). Since S. mutans has been identified as the primary etiologic 
bacteria of dental caries, the effect of a single smoking tobacco component like nicotine 
on the growth of S. mutans has been reported (106). However, there are more than 6,000 
compounds in cigarette tobacco (47). The collective influence of these components on S. 
mutans remains unclear, especially for its cariogenic virulence factors such as bacterial 
attachment and acid generation. 
 
The purpose of the current study was to investigate the virulence factors of S. mutans in 
response to cigarette smoking condensate (CSC) treatment by comparing the growth and 
sucrose-dependent adherence of S. mutans and S. gordonii treated with CSC, as well as 
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sucrose-independent adherence and acid generation of the treated and untreated S. 
mutans. 
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2. Oral health status, smoking and cardiovascular diseases 
Cardiovascular diseases (CVD) are the leading cause of death in the United States and 
account for nearly 38% of all deaths in America (161). Several traditional risk factors 
have been identified for the development of CVD including age, blood levels of total and 
low level of high-density lipoprotein cholesterol, smoking exposure, hypertension, and 
diabetes mellitus (229). Recently, some novel risk factors such as oral health status and 
C-reaction proteins have also been linked to CVD (81). 
 
Atherosclerosis is the major contributor to CVD and cardiovascular deaths including 
coronary heart diseases (CHD), stroke, and general atherosclerotic heart disease. 
Atherosclerosis is a complex process and caused by the interaction of numerous causative 
agents involving inflammation and innate immunity, as well as a disorder of lipid 
accumulation (32). The development of atherosclerosis is also a long-term process which 
can be divided into two distinct steps-injuries to the arterial wall and response to injury. 
There is no doubt that inflammation plays an important role in the development of 
atherothrombosis in which an excessive inflammatory subset of monocytes/macrophages 
has been found (128). 
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2.1 Smoking and CVD-Epidemiological evidence 
The impact of tobacco smoking on human health is well documented. It has been 
reported that cigarette smoking is a major cause of coronary heart disease, stroke, aortic 
aneurysm, and peripheral vascular disease (32). In a meta-analysis of 32 studies, the 
overall relative risk of stroke associated with cigarette smoking was 1.5 with a 95% 
confidence interval (CI) between 1.4 to 1.6 (195). Moreover, this association was 
dependent on age, in which relative risks (RRs) were 2.9, 1.8 and 1.1 for age groups of 
less than 55 years, between 55 to 74 years and around 75 years or older, respectively. In 
another case-control study, a history of smoking was also significantly linked to the 
incidence of acute myocardial infarction (MI) with adjusted odds ratio of 1.81 (95% CI, 
1.75-1.87) (46). 
 
It was estimated that consumption of 10 cigarettes per day might increase cardiovascular 
mortality in men by 18% and in women by 31% (32, 103). Approximately 140,000 
premature deaths from cardiovascular diseases each year have been attributed to smoking 
exposure. The smoking-attributable deaths from ischemic heart disease, cerebrovascular 
disease, and a cluster of other cardiovascular diseases were estimated based on the data 
from 14 epidemiological subregions of the world for all ages (59). It was found that of 
about 1.62 million cardiovascular deaths in the world, 11% were due to smoking. In 
another study, smoking contributed almost 30% of total global cardiovascular deaths (60). 
The different estimates might be caused by the different constitution of the study 
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population and calculation methods. However, the uncertainty also suggested the need for 
further research to investigate the interaction of smoking with other CVD risk factors as a 
cluster in an epidemiology study and biological interactions between smoking and other 
risk factors that might cause this uncertainty. 
 
Obviously, smoking is involved in all phases of atherosclerosis development because the 
tobacco components participate in thrombosis, cause endothelial dysfunction and induce 
coronary vasoconstriction (7). Other risk factors also play roles in the pathogenesis of 
atherosclerosis. When multiple risk factors present in one individual, they might 
“magnify” each other to accelerate the progress of atherosclerosis formation (59). 
 
2.2 Oral health status and CVD-Epidemiological evidence 
As early as 1987, Mattila et al. (150) investigated the association between poor dental 
health and acute myocardial infarction in two separate case-control studies. Two dental 
health indices measuring caries and periodontal status were significantly related to acute 
myocardial infarction, even after adjustment for traditional risk factors like age, social 
class, smoking, serum lipid concentrations, and the presence of diabetes. The authors 
indicated that dental caries or periodontal diseases, or both are associated with acute MI. 
After that, poor oral health status has been reported to have a positive association with 
cardiovascular disease (CVD) including atherosclerosis, myocardial infarction and stroke 
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by many studies applying a variety of markers to measure the burden of oral 
diseases/infection (52, 68, 221). 
 
In a prospective cohort study, it was found that both periodontal diseases and poor oral 
hygiene were associated with coronary heart disease (CHD) among a national sample of 
American adults aged 25 to 49 (52). The maximum relative risk for CHD was about 2.0 
for both the periodontal index and oral hygiene index. However, previously Mattila‟s 
study demonstrated almost a 10-fold increased risk of acute MI for people with a higher 
dental index which measured both caries and periodontal disease (150). Besides different 
study designs and populations in these two investigations, the dental index used in the 
first study included the severity of caries and periodontal diseases, which implied that 
these two dental infectious diseases both contributed to CHD. 
 
However, not all epidemiologic studies found an association between periodontal 
diseases and CVD (89). One of the most important reasons was the diverse measurements 
of periodontal diseases ranging from self-reported periodontal diseases, partial recording 
of attachment, the number of teeth left, and the Russell plaque index to clinical 
attachment loss (CAL) and alveolar bone level (ABL). Moreover, none of these indices 
was able to measure another dental infection-dental caries. Therefore, it is hypothesized 
that the number of teeth removed may be a more accurate indicator of total dental 
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infection burden to measure the relationship between oral health and CVD, especially in 
cross-sectional studies (221). 
 
Based on a population-based study in northeast Germany, tooth loss was considered as an 
independent risk factor of acquired aortic valve sclerosis (AVS) (221). Compared to those 
with less than 5 teeth lost, the odds ratio for individuals with all teeth removed was 1.97 
(95% CI, 1.31-2.96). It was further found that plasma fibrinogen levels increased among 
those with AVS, which indicated that chronic inflammatory processes may be involved in 
AVS development. 
 
The relationship between the number of teeth present/periodontal diseases and the 
incidence of coronary heart diseases was investigated among a US sample of 44,119 male 
health professionals (99). It was found that among people with pre-existing periodontal 
diseases, subjects with less than 11 teeth remaining were at a higher risk of CHD than 
those with 25 or more teeth (RR around 1.67; 95% CI, 1.03-2.71). 
 
The strength of the association between oral health and CVD was varied in studies using 
cohort, cross-sectional, or case-control designs (97). And some of the prospective studies 
failed to demonstrate this association (89, 149). Thus, it is argued that this association 
may be a coincidental association rather than a causal relationship, because dental health 
can be regarded as a general indicator of personal hygiene and possibly health care 
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practices. The modern concepts of causality include “biological plausibility” as one of the 
criteria (83), which may help to clarify if oral bacteria involved in atherosclerosis plaque 
are real pathogens or only bystanders. 
 
2.3 Oral health status and CVD-General biological mechanisms  
2.3.1 Direct and indirect pathways of oral bacterial infection for CVD 
The potential association of poor oral health status and systemic chronic diseases has 
been proposed for more than a century, which originated from the “focal infection 
theory” (90). Until 1993, the severity of coronary atherosclerosis was linked to the 
severity of dental infections in both cross-sectional and longitudinal studies (151, 221). 
This relationship was independent of age, blood lipids, body mass index, hypertension, 
smoking and social class. Later, Desvarieux et al. provided the first direct evidence which 
demonstrated that the accumulative periodontal bacterial burden checked by DNA-DNA 
checkerboard hybridization was independently associated with the mean carotid artery 
intima-media thickness (53). The detection of oral bacterial in atheromatous plaque 
confirmed the relationship between oral health status and CVD (164, 234). The oral 
microbes found in atheromatous plaque specimens included Porphyromonas gingivalis (P. 
gingivalis), Aggregatibacter actinomycetemcomitans and S. mutans, etc. It has been 
demonstrated that not only dental procedures but also gentle mastication and 
toothbrushing can induce bacteremias among periodontitis patients (66). In general, the 
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potential biological mechanisms of oral bacterial infection for CVD can be classified as 
direct pathways and indirect pathways (48). 
 
Invasive P. gingivalis with surface-associated fimbriae has been demonstrated to invade 
and sustain growth in human vascular cells (50-51). In response to P. gingivalis infection, 
Human Umbilical Vein Endothelial Cells (HUVECs) begin to express intercellular 
adhesion molecule 1, monocyte chemoattractant protein-1, vascular cell adhesion 
molecule 1 and P- and E-selectins (111). All of these adhesion molecules are involved in 
the recruitment of leukocytes to inflammation sites contributing to atherosclerosis 
progression. P. gingivalis also directly induces macrophage transformation into 
cholesteryl ester-rich macrophage foam cells, which is a hallmark of early fatty streak 
lesions in atherosclerosis and crucial for the initial buildup of cholesterol in the arterial 
wall intima (180). It was suggested that P. gingivalis and its vesicles induce 
cellular-mediated modification of native low-density lipoproteins and LDL aggregation 
by directly degrading apoB-100 of LDL, which sequentially could stimulate foam cell 
formation. In a recent study by using an apoE-knockout mice model, it was further 
demonstrated that the selective proteolytic cleavage
 
of apoB-100 in LDL particles was 
mediated by the unique class of cysteine proteinase-Arg-gingipains
 
produced by P. 
gingivalis (78).  
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As for the indirect pathway, the long-term local exposure to periodontal pathogens has 
been implied to stimulate systemic inflammation responses that enhance proatherogenic 
effects (179). Epidemiologic evidence suggests that periodontal diseases are associated 
with elevations in systemic
 
levels of proinflammatory acute-phase proteins such as 
C-reactive protein (CRP) and fibrinogen and treatment can significantly decrease the 
levels of these biomarkers (48). Molecular studies confirmed that in response to 
microbial stimulation like P. gingivalis and A. actinomycetemcomitans, host cells release 
proinflammatory cytokines, such as interleukin-1, tumor necrosis factor alpha, and IL-6 
systemically (179). Then, these cytokines and/or chemokines induce the production of 
CRP by the liver. Many studies have found that even a modest elevation in the levels of 
CRP were associated with development of CVD (6, 70, 113). Thus, chronic, low-grade 
oral infections ultimately modulate atherogenesis by exacerbating vascular inflammation 
through potential stimuli including transient bacteremias and lipopolysaccharide.   
 
Autoimmune inflammatory responses have been suggested to take part in the 
pathogenesis of atherosclerosis. The involved mechanisms are molecular mimicry and 
epitope spreading to generate atherosclerosis (138). The cross-reactivity of antibodies to 
bacterial proteins with homologous proteins on endothelial cells such as heat shock 
proteins (HSPs) has been studied (64-65). Ford et al. (65) revealed anti-GroEL (HSP60) 
and anti-P. gingivalis antibodies cross-reacted with hHSP60 in atherosclerosis patients. In 
another in vitro study, they also found cross-reactivity in a number of GroEL- and 
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hHSP60-specific T-cell lines to hHSP60 and GroEL, respectively (64). Moreover, the 
artery T-cell lines specific for GroEL, hHSP60, and P. gingivalis were dominant with the 
Th2 phenotype of the CD4 subset and Tc0 phenotype of the CD8 subset with a high 
proportion of CD8 cells expressing the chemokines IP-10, RANTES, monocyte 
chemoattractant protein-1, and MIP-1α. Therefore, it was hypothesized that the 
cross-reactivity of antibodies to bacterial HSP60 (GroEL) with hHSP60 on endothelial 
cells can lead to endothelial dysfunction and atherosclerosis formation.  
 
2.3.2 Oral bacteria and infective endocarditis 
Infective endocarditis (IE) as a subtype of CVD is caused by bacterial vegetations which 
occur on previously damaged or congenitally malformed cardiac valves or endocardium. 
Although it is rare with an incidence rate around 2.0-6.2 cases per 100,000 people/year 
(137), it is life-threatening with a mortality rate as high as 30% (171). IE has been 
correlated to oral bacterial infections for a long time. It has been estimated that more than 
80% of all cases of IE are caused by Staphylococcus aureus, Streptococcus spp. and 
Enterococcus spp. (84). 
 
To date, despite the increased detection of staphylococcal infections in IE cases (63, 84), 
previously about 8-11% of IE cases were associated with untreated dental or gingival 
diseases and approximately 14-20% of IE patients exposed to dental treatment several 
weeks before the onset of IE symptoms (56, 140, 212).  
31 
A typical IE case may begin in the bloodstream of patients with a congenital heart defect, 
where the infecting bacterial cells and host matrix molecules and platelets will interact. 
Eventually a vegetation is formed at the sites of damaged endocardial tissues. But for 
patients with intact valvular tissue, some microorganisms such as viridans streptococci 
have been suggested to directly adhere to normal valves, damage cardiovascular 
endothelium and ultimately lead to the formation of vegetative or atheromatous plaque 
(202). This theory has been partially documented by in vitro experiments, which have 
demonstrated that the attached streptococci are able to invade and kill cultured HUVECs 
by alpha-hemolysin production or by lowering the pH (202). 
 
P. gingivalis and viridans streptococci also have the ability to aggregate human platelets 
in platelet-rich plasma (41). Arginine-specific gingipains-R
 
produced by P. gingivalis 
efficiently increased intracellular calcium in human platelets at nanomolar
 
concentrations 
and caused platelet aggregation with efficiency
 
comparable to thrombin (135). In the case 
of viridans streptococci, S. gordonii has the ability to induce platelet
 
adhesion via protein 
Hsa binding to platelet GPIbα (110). Meanwhile, platelet aggregation was mediated by 
three proteins, Hsa, SspA, and SspB.  
 
Therefore, based on the evidence from epidemiological and in vitro studies discussed 
above, oral bacteria are more likely to be involved in CVD as causative pathogens than as 
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bystanders. The ability of bacterial adherence to endothelium is critical to invoking an 
inflammatory response and cause diseases. 
 
2.4 Bacterial attachment to host tissues  
Atherosclerotic plaque begins soon after birth and might become significant before age 
40 (153). The reasons why some subjects develop atherosclerosis so quickly still remain 
unclear. There is no doubt that classic risk factors such as smoking are causally associated 
with atherosclerosis. However, there are still 15 to 20% of patients who develop 
atherosclerotic plaque in absence of these traditional risks (112). Novel risk factors like 
oral infection have been identified in epidemiological and in vitro studies as well as in 
animal models (7).  
 
Over 700 species of bacteria have been identified in the human oral cavity (4), but only a 
small fraction of oral bacteria have been associated with distant site infections. Different 
species have different abilities to interact with host cells via different ligand-receptor 
mechanisms. Among them, viridians streptococci are frequently found in the specimens 
of patients with IE or atherosclerosis. It is believed that this association depends on 
unique virulence factors of the infecting microflora, such as the ability to adhere to host 
tissue.  
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Streptococcus viridans, including S. mutans, S. oralis and S. gordonii etc, are dominant in 
the human oral cavity, belong to the family of Streptococcaceae (Gram-positive bacteria) 
and have been classified as -hemolytic streptococci. They are human commensal 
bacteria, but are also associated with infectious diseases such as dental caries, 
endocarditis and rheumatic fever (75, 201).  
 
S. mutans, which naturally inhabits dental plaque, has been considered as the primary 
pathogen of dental caries, and is linked to bacteremia and infective endocarditis (16, 75). 
S. mutans contributed to about 20% of endocarditis cases caused by viridans streptococci 
(16). Recently, S. mutans was also detected more frequently in the specimens of heart 
valve (69%) and atheromatous plaque (74%) than other pathogens related to periodontitis 
(164). This semiquantitative assay revealed that the bacterial composition in 
cardiovascular tissues had only a limited number of species and was distinct from that in 
dental plaque. However, S. mutans was detected in significant quantities in specimens of 
heart valve (40%) and atheromatous plaque (48%). The same research group conducted a 
further investigation, which collected bacterial samples of dental plaque and 
cardiovascular specimens from patients who underwent heart valve replacement or 
removal of aortic aneurysms (165). It was found that the S. mutans was present in 78% of 
both cardiovascular specimens and dental plaque, which was significantly higher than 
any other 5 oral streptococcal and 6 periodontal bacterial species. This result indicated 
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that S. mutans detected in the cardiovascular regions may possibly originate from the oral 
cavity.  
 
2.4.1 Adhesins 
Undoubtedly, bacterial adherence to endothelium is the first and crucial step for 
infectious diseases. For example, in a typical IE case bacteria need to bind to injured 
endothelium with exposed extracellular matrix (ECM) like fibronectin and collagen. And 
in an atypical IE case, the interaction between the adhesins on the bacterial surfaces and 
the receptors on the host cells is required for bacterial attachment (202). 
 
Bacterial adherence to human endothelial cells and to fibronectin-coated surfaces has 
been studied (218). Staphylococcus aureus and viridans streptococci demonstrated strong 
binding ability to the fibronectin-coated surfaces and endothelial cell monolayer. 
Furthermore, S. aureus pretreated with serum or purified Fn showed enhanced attachment 
to endothelial cells. It was therefore suggested that fibronectin-fibronectin interactions in 
bacterial attachment might occur. Chia et al. (36) also found that S. mutans could bind to 
both soluble and immobilized Fn derived from human plasma, but S. gordonii and 
S. sanguis were unable to bind to the soluble form of Fn in plasma. It is indicated that S. 
mutans bound to sFn has more chances to attach to host tissue via Fn-Fn, Fn-collagen and 
Fn-integrin interaction. 
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S. mutans produces a variety of cell surface proteins which bind to host receptors. The 
major cell surface adhesins of S. mutans include antigen I/II (22) and three types of 
fibronectin-binding proteins (36, 155). Here, we will focus on the roles of antigen I/II in 
bacterial interaction with host tissue.  
 
Antigen I/II 
The Ag I/II family polypeptides are cell wall anchored adhesins with molecular weights 
ranging from 180 to 210 kDa and are expressed by most oral streptococci (98). Basic 
information about antigen I/II has been introduced in the introduction Part 1. The 
complex structure has multiple ligand-binding sites to interact with a wide range of host 
molecules such as salivary agglutinin glycoprotein (96) and ECM proteins including 
fibronectin, laminin, type I collagen, and fibrinogen (192).  
 
An antigen I/II-deficient S. mutans isogenic mutant has been shown to have a reduced 
binding ability to immobilized fibronectin and collagen (22), and is essentially unable to 
adhere to laminin films (33). For instance, the binding ability of the mutant strain to Fn 
was only 50% of the parental strain. Although S. mutans wild type cells (NG8) adhered to 
collagen less well than did S. gordonii DL1 cells, the adhesion of isogenic antigen I/II 
mutant strain of NG8 to collagen was only 20% of that of wild-type strain (136).  
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Lee et al. clearly observed that antigen I/II was associated with the fibrillar fuzzy layer on 
the surface of S. mutans NG8 and the antigen I/II mutant strain lost this fibrillar structure 
(126). Moreover, the mutant strain did not display the ability of saliva-mediated 
aggregation and adherence, which implied that either the fibrillar material was composed 
of antigen I/II or that antigen I/II was important for the bacterial attachment to the cell 
surface. Surface fibrillar structures have also been suggested as important for the 
attachment of streptococci to epithelial cells (69). Trypsin-treated cells of S. salivarius 
had impaired adherence to epithelial cells due to the removal of the fibrillar fuzzy coat of 
the organism.  
 
Antigen I/II also is able to bind to human blood components such as soluble Fn (107). 
This study also revealed the reason why antigen I/II possesses a diverse binding 
capability using an infrared measurement approach (107). It was found that the 
interaction between antigen I/II of S. mutans OMZ175 with fibrinogen or fibronectin 
induced structural changes in antigen I/II. The results indicated that antigen I/II with a 
“soft” structure might contact with other proteins by forming intermolecular 
beta-structures, which enables S. mutans to interact with diverse host molecules by a 
non-selective mechanism.  
 
To date, most studies of the antigen I/II binding ability have focused on two 
well-conserved regions, the N-terminal A-region and the middle P region. It was reported 
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that the A-region mediated streptococcal aggregation with fluid phase salivary agglutinin 
(SAG) (30) as well as bacterial attachment on SAG-coated hydroxyapatite (40). More 
evidence proved that the A-region was able to bind to human extracellular fibrous 
proteins and that an extended V region (residues 448-844) interacted with sugar residues 
of receptors present in saliva or expressed on the surface of epithelial cells (192). It is 
also hypothesized that N-terminal region sequences are involved in collagen recognition 
(136).  
 
The P-region is involved in self-aggregation and also possesses a functional domain for 
salivary binding (163), which is located on a P region flanking a carboxy-terminal 
sequence (residues 1005-1044) (109). Collectively, there are at least two binding sites in 
antigen I/II that interact with salivary components-the most conserved region within 
residues 816 to 1213 and the A-region within residues 186 to 469 (40, 160). Additionally, 
the P-region is also important for the proper folding of the antigen I/II proteins (28). To 
date, there is no information about which regions are responsible for bacterial interaction 
with Fn.  
 
Fibronectin-binding proteins 
Several fibronectin-binding proteins (FnBPs) have been identified on the surface of oral 
streptococci. These FnBPs are similar in structure. They are all surface proteins and most 
of them have a typical structure with a signal peptide sequence for secretion, a LPXTG 
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motif for cell wall anchoring, and a fibronectin-binding domain composed of several 
amino acid repeat sequences.  
 
S. mutans expresses multiple FnB proteins. Chia et al. (36) identified two FnBPs on the 
surface of S. mutans cells with molecular weights around 55 and 130-kDa. Recently, 
another atypical FnBP with a molecular weight around 63 kDa was identified by 
searching a gene from a BLAST search of the S. mutans genome sequence (155). Amino 
acid alignment comparisons revealed that this protein shared significant sequence 
homology with FnBPs produced by other streptococcal species. These FnBPs 
demonstrated the ability to bind to immobilized Fns and are immunologically similar to 
the FBP54 proteins of S. pyogenes.  
 
Other bacterial surface proteins 
In additional to antigen I/II and FnB proteins, bacteria also produce other surface proteins 
to facilitate binding to host tissue. GTFs are well-known virulence factors of S. mutans 
for dental caries, which synthesize glucan from sucrose for bacterial sucrose-dependent 
adherence. GTFs also contribute to the bacterial attachment to the host. GTF-deficient S. 
mutans isogenic mutant strains have shown lower numbers of colony counts recovered 
from fibrin plates than the wild-type (159). Surface-localized GTF of S. gordonii was 
able to mediate bacterial adhesion to HUVECs in vitro by polysaccharide production (42, 
216).  
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2.4.2. Fibronectin receptor  
It is believed that extracellular matrix (ECM) proteins act as important receptors for 
bacterial attachment. Fibronectin, one of the key components of ECM, has been regarded 
as a major target for bacterial attachment in humans (93). There are two major types of 
Fn-one type is circulating in the plasma and extracellular fluids as soluble fibronectin 
(sFn) and the other type is insoluble and associated with the cell surface (cFn). 
Endothelial cells can produce both sFn and cFn. They are similar in structure and 
function, but are not identical due to alternative splicing (21). Fn is a dimeric 
glycoprotein with a high molecular weight around 440 kDa. Fn is widely distributed and 
has been considered as a bridge between cells and the interstitial collagen meshwork 
(189). One of the important functions of Fn is to bind to a wide variety of other 
macromolecules such as bacterial surface proteins. 
 
Usually, ECM components are not exposed or deposited on healthy vascular tissues. For 
example, sFns are only immobilized on the damaged endocardial surface and could act as 
a receptor for bacterial attachment. Additionally, the expression of Fn is quite low around 
healthy mature blood vessels, but it is strongly up-regulated by tumor cells, around 
reactive angiogenic vessels during wound healing or in many pathophysiological 
conditions like rheumatoid arthritis, vascular intimal proliferation and atherosclerosis (21, 
91). An increased level of plasma Fn has been observed among CVD patients and a large 
increase in Fn was found in atherosclerotic plaques (26).  
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Smoking has the potential to damage the cardiac endothelium of healthy smokers. In a 
clinical study of plasma levels of cellular Fn in diabetes, results revealed that current or 
past cigarette smoking history were independently associated with an increase in 
circulating cFn (104). Besides binding to bacteria, Fns also contain domains that bind to 
other ligands such as collagen, fibrinogen, thrombospondin and other Fns (27). Therefore, 
Fns can form a foundation for additional ECMs like collagen and laminin, which may 
ultimately build up on the endothelial basal lamina and narrow the vessels. The 
specimens of the proximal saphenous vein from heavy smokers showed ultrastructural 
changes with thickening of the endothelial basal lamina and a specific accumulation of 
Fn in the thickened basal lamina when compared to the specimens from non-smokers 
(82).  
 
Most of the previous studies focused on bacterial adherence to platelet-fibrin matrices or 
bacterial adherence to individual ECM components. It is known that both smoking and 
dental infections are independent risk factors for CVD. It is still unclear if tobacco 
smoking will enhance bacterial attachment to fibronectin and endothelial cells by 
increasing the expression of the adhesins and receptors. No such conclusive studies have 
been performed to evaluate the binding abilities of S. mutans to Fn and endothelial cells 
in presence of smoking condensate and investigate the role of antigen I/II in the bacterial 
attachment. Since host cells possess a diversity of receptors for these adhesins, bacterial 
attachment to immobilized Fn does not necessarily mean that bacteria have the same 
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ability to adhere to host cells, especially under smoking stimulation. To better understand 
the combined effect of smoking and dental infection on the development of CVD, it is 
important to examine the host-bacterium interaction by using mammalian cells that 
possess complex sets of receptors and integrins.  
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MATERIALS AND METHODS 
1. The relationship between smoking and tooth loss-epidemiological data analysis 
The Behavioral Risk Factor Surveillance System (BRFSS) in the U.S. is an ongoing 
computer-assisted telephone interviewing system to collect data on many of the behaviors 
and conditions that may be risk factors for chronic diseases of adults. Data are collected 
monthly from a representative sample living in all 50 states, the District of Columbia, 
Puerto Rico, the Virgin Islands, and Guam. The details of the data collection procedures 
have been described before (170). Briefly, this state-based surveillance system is 
supported by the Centers for Disease Control and Prevention. The non-institutionalized 
U.S. population (aged ≥18 years) is randomly selected by an independent probability 
sample of households with telephones. This sampling method is designed to provide 
national estimates when all state data are combined (156). The data contain no identifying 
information and are free for the public to download. The 2006 BRFSS database used in 
the current study were obtained from the CDC website (34). 
 
Besides demographic and socioeconomic information, the data used for this analysis were 
divided into three main categories: behavioral health risk factors (i.e., smoking status, 
alcohol consumption, and physical activities), the general health status (i.e., if have ever 
been diagnosed with diabetes and body mass index), the oral health status (i.e., the 
number of permanent teeth removed due to tooth decay or gum disease). 
 
43 
1.1 Definition of outcome variable 
The number of teeth removed was considered as the outcome variable, which was based 
on the question “How many of your permanent teeth have been removed because of tooth 
decay or gum disease? Do not include teeth lost for other reasons, such as injury or 
orthodontics.” The predefined response was categorized into none, 1 to 5, 6 or more but 
not all, and all.  
 
1.2 Definitions of important explanatory covariates 
Smoking status: A never smoker was defined as someone who had never smoked more 
than or equal to 100 cigarettes. A former smoker was defined as someone who had 
smoked at least 100 cigarettes but was no longer smoking. A current smoker was defined 
as someone who had smoked at least 100 cigarettes and was currently smoking. The 
current smokers were categorized into two subgroups-currently smoking every day and 
currently smoking some days.   
 
Alcohol consumption: The level of alcohol consumption was assessed by the following 
question: “During the past 30 days, have you had at least one drink of any alcoholic 
beverage such as beer, wine, a malt beverage or liquor?” In the current analysis, heavy 
drinkers were defined as having more than two drinks per day for adult men and having 
more than one drink per day for adult women. 
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Physical activity in the leisure time: This variable was identified by asking “During the 
past month, other than your regular job, did you participate in any physical activities or 
exercises such as running, calisthenics, golf, gardening, or walking for exercise?” A 
positive response was considered as “Had physical activity or exercise”.  
 
Regular dental check-up: The subjects were asked “How long has it been since you last 
visited a dentist or a dental clinic for any reason? Include visits to dental specialists, such 
as orthodontists?” The predefined response was categorized into “Within the past year (< 
12 months ago)”, or “Within the past 2 years (1 year but < 2 years ago)”, or “Within the 
past 5 years (2 years but < 5 years ago)” or “5 or more years ago”. 
 
Self-reported diabetes: The diabetes was identified if they had been told by a doctor or 
other health professional that they had diabetes other than during pregnancy. 
 
Body mass index: The body mass index (BMI) was on the basis of self-reported weight 
and height. A respondent was classified as normal if BMI was less than 2500, overweight 
if the BMI was between 2500 and 3000, and obese if the BMI was more than 3000.   
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1.3 Analytical sample  
A total of 355,710 subjects 18 years or older responded to the 2006 BFRSS. Respondents 
with incomplete key variables were excluded. The final analyzed sample size was 
314,986. 
 
1.4 Statistical analysis 
The distribution of demographic (gender, race and age etc), social-economical variables 
(education level and annual income), health behavior risk factors (smoking and alcohol 
consumption, etc.) and general health status (diabetes and BMI) across the category of 
the number of teeth removed was calculated and tested by using the X
2
 test. The 
percentage of population grouped by the number of teeth removed due to caries or 
periodontal diseases was calculated for the three age groups (18-34, 35-64 and 65 or 
older), and as well as for their smoking status.  
 
The risks of demographic characteristics, social-economical status, health behaviors and 
general health on the number of teeth removed were estimated as relative risks with 95% 
confidence intervals (95% CI) by using an ordinal logistic regression model.  
 
The population attributable fractions were calculated based on the following formula 
(181): Pe(RR–1)/[Pe(RR–1)+1] 
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Pe=the percentage of the population exposed to the risk factor of interest  
RR=the adjusted relative risk of interest 
 
The analysis was performed with SPSS version 17.0 for windows (SPSS Inc., Chicago, 
IL, USA) software. The level of significance was set at p<0.05.  
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2. In vitro effect of cigarette smoke condensate on the cariogenic virulence factors of 
oral streptococcus  
2.1 Bacterial strains, growth conditions and CSC  
S. mutans UA159, NG8, PC3370 (antigen I/II-deficient strain of NG8) and S. gordonii 
DL1 stored at -80 °C in glycerol were used for the current study. For each experiment, 
bacterial cells were cultured in Todd-Hewitt broth (THB, Acumedia, Baltimore, MA) in a 
5% CO2 air incubator at 37 °C. The culture media for PC3370 was supplemented with 
tetracycline (15 µg/ml) as required (39). 
 
CSC was purchased from Murty Pharmaceuticals (Lexington, KY). Based on the 
manufacturer‟s information, CSC was prepared by using a Phipps-Bird 20-channel 
smoking machine designed for Federal Trade Commission testing. Smoke particulates 
were collected on Cambridge glass fibre filters from University of Kentucky's standard 
cigarettes (1R3F; University of Kentucky, KY) and dissolved in dimethylsulphoxide 
(DMSO) at 40 mg/ml. Every cigarette yielded 26.1 mg of CSC with 2.4% of nicotine.   
 
2.2 The effect of CSC on bacterial viability 
Susceptibility testing 
The minimum inhibitory concentration (MIC) and minimum bactericidal concentration 
(MBC) of CSC against the two different bacteria were compared by the micro-dilution 
method as described previously with some modifications (198, 226). Briefly, to determine 
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MIC, two-fold serial dilutions of CSC were prepared in THB and placed in sterile 
96-well flat-bottom microtiter plates (Costar, Cambridge, MA) with the final 
concentrations ranging from 0.5 to 8.0 mg/ml. Then, diluted bacterial suspensions were 
added to each well (final concentration 1 × 10
4
 CFU/ml) and the plates were incubated 
for 24 to 48 hours at 37 
o
C. The turbidity was measured by optical density (OD) at 595 
nm using a microplate reader (SpectraMax 190; Molecular Devices, Inc., Sunnyvale, CA) 
at the beginning of the study and after 24 and 48 hours of incubation. The MIC was 
defined as the lowest concentration of CSC that was without an obvious optical density 
change after 48 hours of incubation. To determine the MBC, bacterial media from the 
wells without an obvious optical density change were plated on Tryptic Soy Agar (TSA, 
Difco, Detroit, MI) plates and incubated for 48 hours. The MBC was defined as the 
lowest concentration that did not have any visible bacterial growth on the agar plates 
(99.9% killed).  
 
Time-kill assay 
A time-kill assay for both bacteria was conducted by the method described previously 
with some modifications (198). The concentrations of CSC used for the time-kill assay 
were 2, 4 and 6 mg/ml, which was at or higher than the MIC of S. gordonii determined by 
the MIC assay. Overnight bacterial cultures were harvested and resuspended in fresh 
THB media with an OD595 around 1.0. 10 µl of the bacterial culture was incubated in 1 
ml of THB media with 2, 4 or 6 mg/ml of CSC at 37 °C (final concentration 1× 10
6
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CFU/ml). The number of viable cells treated with or without CSC was determined at 0 
and 30 min and 1, 2, 4 and 8 hours by plating bacterial media onto TSA plates. After 48 
hours of incubation at 37 °C, the number of colonies was counted.  
 
Growth rate 
The effect of CSC on the growth rate of S. mutans and S. gordonii was determined at 
sub-MIC levels. Overnight bacterial cultures were diluted 1:20 in 96-well microtiter 
plates containing 250 µl THB with serial 2-fold dilutions of CSC from 0.0625 to 1 mg/ml 
and incubated with 5% CO2 at 37 °C. Bacterial growth was monitored by a microplate 
reader (SpectraMax 190; Molecular Devices) at OD of 595 nm every 30 min for 12 hours. 
The growth rate was expressed in terms of the duration of lag phase and doubling time 
(198).  
 
2.3 Effect of CSC on sucrose-dependent adherence 
Sucrose-dependent adherence 
The sucrose-dependent adherence assay was conducted as described by Kawabata and 
Hamada (105). S. mutans and S. gordonii were incubated at 37 °C at a 30 degree angle in 
a glass culture tube (13 x 100 mm) containing 3 ml of THB broth supplemented with 1% 
sucrose and different concentrations of CSC (0, 0.0625, 0.125 and 0.25 mg/ml). After 18 
hours of incubation, the non-adherent cell suspension was transferred to tube A (fraction 
A). After addition of 3 ml of fresh THB to the original tube, the tube was gently rotated to 
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detach loosely bound bacterial cells which were added to tube A (fraction A). Another 3 
ml of THB media was added to the original tube and the tightly adherent cells were 
dissociated completely by means of a sonicator at low power (Branson Sonifier 450, USA) 
(fraction B). The turbidity of each faction was determined at OD595. The percentage of 
tightly adherent cells was defined by the percentage of B/A+B (with A and B representing 
the turbidity of each fraction).  
 
Dextran binding assay 
The effects of CSC on dextran-binding of S. mutans and S. gordonii were examined (146). 
Bacterial cells were cultured in THB with different concentrations of CSC (0, 0.0625, 
0.125 and 0.25 mg/ml) overnight, then harvested, washed in phosphate-buffered saline 
(PBS) twice and re-suspended in PBS to an OD595 of 0.25. 100 µl of prepared bacterial 
culture per well were coated in 96-well flat-bottom microtiter plates (Costar, Cambridge, 
MA) at 4 °C overnight. After washing with distilled water three times, each well was 
blocked with blocking buffer (0.5% bovine serum albumin in 10 mM sodium acetate 
buffer, pH 6.0) at 37 °C for 2 hours. After a second wash, 100 µl of biotin-dextran (final 
concentration 0.5 µg/ml and molecular weight of 70,000 daltons; Marker Gene 
Technologies, Inc., Eugene, OR) was added to each well. After 15 minutes of incubation, 
the plate was washed, 50 µl of 1:1,000 streptavidin-peroxidase (Sigma-Aldrich, St. Louis, 
MO) added and incubated at room temperature for another 15 min. After a final wash, 
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o-phenylenediamine (Sigma) color detection agent was applied and the color reaction 
was determined at OD490 after 30 min incubation at room temperature.   
 
2.4 Effect of CSC on the expression of GTF and Gbps 
Bacteria grown in THB treated with CSC (0, 0.0625, 0.125 and 0.25 mg/ml) were 
harvested at late-log phase and washed twice with PBS. The surface proteins were 
extracted by resuspending the bacterial pellet in 100 µl of 2x cracking buffer (0.0375 M 
Tris, 1% SDS, 2.5% 2-mercaptoethanol and 15% glycerol) (17). After 2 hours of 
incubation at room temperature, suspensions were collected by centrifuging to pellet cell 
debris and the protein concentrations in the supernatants were determined by using the 
Quick Start 
TM
 Bradford assay (Bio-Rad Laboratories, Hercules, CA). To compare the 
GTFs and Gbps expressed by treated and untreated bacteria, proteins were separated by 
8% SDS-PAGE gel electrophoresis using the method of Laemmli (122). After 
electrophoresis, proteins were transferred to a polyvinylidene fluoride (PVDF) 
membranes. Then, the membranes were blocked with 3% non-fat milk in PBS-Tween 20 
for 1 hour at room temperature, followed by incubation with anti-GTF and anti-GbpB 
(kindly supplied by Dr. Daniel Smith, Boston, MA), and anti-GbpA (a gift from Dr. Jeff 
Banas, Albany, NY) antibodies overnight at 4 
o
C. After multiple washes with PBS-Tween 
20, the membranes were incubated at room temperature for 1 hour with appropriate 
secondary antibodies (Sigma). The protein bands were visualized by enhanced 
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chemiluminescence (ECL; Pierce Chemical Co., Rockford, IL). The intensity of protein 
bands was analyzed using NIH ImageJ software version 1.37.  
 
2.5 The effect of CSC on S. mutans sucrose-independent attachment 
Saliva collection 
Unstimulated deidentified human whole saliva was collected from four healthy 
volunteers of both sexes, which was approved by IRB (IRB #0304-64). The pooled saliva 
was centrifuged twice at 10,000x g for 5 min at 10 
o
C and the resultant supernatants was 
1:4 diluted in saline and passed through 0.45 μm and 0.22 μm filters, respectively. The 
pooled saliva was stored at -20 °C before the assay. 
 
Bacterial attachment assay 
50 µl of prepared saliva was coated in 96-well flat-bottom microtiter plates (Costar, 
Cambridge, MA) at 4 °C overnight. After washing with PBS 3 times, the plate was 
blocked with blocking buffer (3% bovine serum albumin in PBS-0.05% Tween 20) at 
37 °C for 2 hours. S. mutans strains UA159, NG8, PC3370 were cultured with 0 or 0.25 
mg/ml CSC overnight. After washing 3 times, bacterial pellets were resuspended in PBS 
with OD595 around 1.2. Then, 1.5 ml bacteria suspensions were mixed with 1.5 mg of 
Biotin N-hydroxysuccinimide ester (Sigma) for 2 hours at room temperature. Unbound 
biotin was removed by centrifugation and washed 3 times with PBS. 50 µl of bacterial 
suspensions in PBS were added to the saliva-coated plate for 15 min. After extensively 
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washing with PBS-0.05% Tween 20, 50 µl of 1:10,000 Streptavidin-Peroxidase (Sigma) 
was added for another 30 min, followed by washing and o-phenylenediamine (Sigma) 
color detection. The color change was measured within 30 min at OD 450 nm.   
 
2.6 The expression of antigen I/II by S. mutans in response to CSC 
Bacteria (UA159) grown in THB treated with CSC (0, 0.0625, 0.125 and 0.25 mg/ml) 
were harvested at late-log phase and washed twice with PBS. The whole cell proteins 
were extracted in lysis buffer (18% sucrose, 10 mM MgCl2, 20 mM Tris-HCl, pH 6.8 
containing 500 units of mutanolysin, and 0.5 mM phenylmethylsulphonyl fluoride, 
0.005% chloramphenicol) as indicated before (95). The protein concentrations were 
determined by using the Quick Start 
TM
 Bradford assay (Bio-Rad Laboratories, Hercules, 
CA). Equal amounts of proteins were separated by 8% SDS-PAGE gel electrophoresis 
and transferred to PVDF membranes. Then, the membranes were blocked with 3% 
non-fat milk in PBS-0.05% Tween 20 for 1 hour at room temperature, followed by 
incubation with anti-antigen I/II antibodies overnight at 4 
o
C. After multiple washes, the 
membranes were incubated at room temperature for 1 hour with appropriate secondary 
antibodies (Sigma). The protein bands were visualized by enhanced chemiluminescence 
(ECL; Pierce Chemical Co., Rockford, IL). 
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2.7 The effect of CSC on acid production by S. mutans 
The effect of CSC on acid production was tested for S. mutans UA159. Bacteria were 
grown in THB overnight and then diluted 1:50 in fresh THB with different concentrations 
of CSC (0, 0.0625, 0.125, 0.25 and 0.5 mg/ml). Bacterial cells were harvested by 
centrifugation at mid-log phase, washed twice with PBS and resuspended in working 
solution with OD595 around 1.50 (2 mM KPB containing 150 mM KCl and 5 mM MgCl2). 
The reaction mixture consisted of 0.5 ml of S. mutans cells and 1 ml of 1% sucrose 
solution. The pH was monitored using a glass electrode (AB15 Accumet, Fisher) every 
15 min over a period of 135 min. The untreated bacterial cells in KPB working solution 
without sucrose were considered as the negative control. The glycolytic pH-drop was 
calculated as: 
pH reduction=the pH value of the negative control-the pH value of treated or untreated 
bacterial cells with sucrose at each time point  
 
2.8 Statistical analysis  
All assays were carried out at least three times, with the results presented as the mean and 
standard deviation. The analysis of variance (ANOVA) or paired t test was used to 
compare the difference between treated groups and the control group with p<0.05 
indicative of a significant difference. 
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3. The joint effect of oral health status and smoking on cardiovascular 
diseases-epidemiological analysis 
The data used to analyze the joint effect of oral health status and smoking on CVD were 
also obtained from the 2006 BRFSS. The details of the study design and data collection 
procedures were described previously. Because the prevalence of cardiovascular diseases 
was much lower among people under 35 years, and in order to eliminate other potential 
confounders related to oral health status and cardiovascular diseases such as nutrition and 
chewing function (222), the combined effect of smoking and oral health status on CVD 
was analyzed only for middle-aged adults (between 35 to 59 years). The number of teeth 
removed due to caries or periodontal diseases was used as a surrogate indicator for oral 
health status. That is, the more teeth that had been removed, the more severe the oral 
health status the subject had.   
 
3.1 Definition of outcome variable  
Self-reported cardiovascular disease (CVD) was used as an outcome variable. 
Respondents were asked “Has a doctor, nurse, or other health professional ever told you 
that you had any of the following-with heart attack/myocardial infarction, 
angina/coronary heart diseases, or stroke”. If the response was positive to any of 
diagnoses above, the subject was classified into the CVD group.  
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3.2 Definitions of important explanatory covariates  
Smoking status: As mentioned before, a never smoker was defined as someone who had 
never smoked more than or equal to 100 cigarettes. A former smoker was defined as 
someone who had smoked at least 100 cigarettes but was no longer smoking. A current 
smoker was defined as someone who had smoked at least 100 cigarettes and was 
currently smoking. In the analysis of the combined effect of smoking and oral health 
status, smokers included both former and current smokers. 
 
The number of teeth removed: Same as in Part 1.  
Physical activity in the leisure time: Same as in Part 1. 
Regular dental check-up: Same as in Part 1. 
Self-reported diabetes: Same as in Part 1. 
Body mass index: Same as in Part 1. 
 
3.3 Statistical analysis   
The distribution of CVD across demographic, and social-economical variables, health 
behavior risk factors and general health status and the number of teeth removed was 
calculated for 5 age groups and tested by using the X
2
 test. The percentages of people 
with CVD were computed among people with different numbers of teeth removed across 
the 5 age groups (35-39, 40-44, 45-49, 50-54 and 55-59 years old).  
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The risks of the number of teeth removed, smoking status (including both current and 
former smokers) and other preventable risk factors for CVD were estimated as relative 
risks (RR) and 95% confidence intervals (95% CI) by using a binary logistic regression 
model and adjusted for gender, race (non-Hispanic White, African American, Hispanic 
and others), five age groups, marital status, education levels, alcohol consumption, 
diabetes, body mass index, annual dental check and leisure activity.  
 
To detect possible interactions between smoking and the number of teeth removed, the 
relative risks of the number of teeth removed on CVD were calculated and stratified by 
the smoking status for subjects; as well as only for smokers across the 5 age groups. 
Meanwhile, a new interaction variable (the number of teeth removed * smoking status) 
was created using the previous logistic regression model. Furthermore, the risk of this 
new variable on CVD was calculated for the 5 age groups so as to examine the joint 
effect of three variables on the multiplicative scale. The reference group was considered 
as the never-smokers with all teeth remaining.  
 
Since it has been suggested that an assessment of the interaction on an additive scale is 
more meaningful than on a multiplicative scale (184), the additive interaction between 
the number of teeth removed and smoking across the 5 age groups was examined as the 
relative excess risk due to interaction (RERI) with 95% confidence intervals. The 
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attributable proportion due to the interaction (AP) was also estimated. The measures of 
the additive interaction were calculated based on RR of interest as described below (235): 
RERI=RR11-RR10-RR01+1.   
RR11=the relative risk of the people exposed to both smoking and the number of teeth 
removed to have CVD 
RR10/RR01=the relative risk of the people exposed to either smoking or the number of 
teeth removed to have CVD 
Attributable proportion due to interaction (AP) =RERI/RR11 
The detailed calculation was described previously by using the method of variance 
estimates recovery (MOVER) (235).  
 
Most of the computations were performed with SPSS version 17.0 for windows (SPSS 
Inc., Chicago, IL, USA) software. The additive interaction calculation was conducted by 
use of the four-by-two table on the Excel spreadsheet as recommended (235). The level 
of significance was set at p<0.05.  
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4. In vitro effect of cigarette smoke condensate on S. mutans attachment to 
fibronectin and HUVECs  
4.1 Bacteria and mammalian cell culture   
S. mutans strains UA159, NG8, PC3370 (antigen I/II-deficient strain of NG8) were 
routinely cultured in Todd-Hewitt Broth (THB; Difco Laboratories, Detroit, MI) and 
grown at 37 
o
C with 5% CO2. The culture media for PC3370 was supplemented with 
tetracycline (15 µg/ml) as required (39).  
 
Human umbilical vein endothelial cells (HUVECs, from Lonza Walkersville, Inc., 
Walkersville, MD) were grown in complete endothelial growth medium (EGM-2) 
supplemented with Bullet kit® (Lonza, Walkersville, MD) and 10% fetal bovine serum. 
The endothelial cells were grown at 37 °C in a humidified 5% CO2 and 95% air incubator. 
HUVECs at passage number 3 to 9 were used for the experiments.  
 
CSC was purchased from Murty Pharmaceuticals (Lexington, KY, USA). The detailed 
information of CSC was described in the materials and methods Part 2.  
 
4.2 CSC treated bacteria bound to the soluble Fn  
Bacterial attachment to soluble Fn-Western blot 
The Fn adsorption assay was conducted based on the method described previously with 
some modifications (36). Briefly, the overnight bacterial cultures (UA159) with 0 or 0.25 
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mg/ml CSC were harvested, washed, and resuspended in phosphate-buffered saline (PBS) 
at OD 595 around 0.6. 500 µl bacterial suspensions were incubated with 0, 8 and 32 µl of 
0.25 mg/ml Fn, which was extracted from human plasma (Sigma), at room temperature. 
The final concentrations of Fn were 0, 16 and 64 µg/ml. After a 15 min incubation, 
bacteria were washed with PBSAT (PBS with 0.02% sodium azide and 0.05% Tween 20). 
Then the bound Fn was eluted from the bacterial surface with 8 M urea, separated by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to a 
PVDF membrane (Millipore, Bedford, MA) and detected by anti-human fibronectin 
antibody (Sigma) for western blot analysis.  
 
Soluble Fn bound to CSC treated bacteria or antigen I/II peptides-ELISA 
S. mutans strains UA159, NG8, PC3370 were cultured with 0 or 0.25 mg/ml CSC in THB 
overnight. After washing 3 times, bacterial pellets were resuspended in PBS with OD595 
around 1.2. Then, 50 µl of the treated bacterial culture was coated in 96-well flat-bottom 
microtiter plates (Costar, Cambridge, MA) at 4 °C overnight. To detect the role of 
bacterial surface proteins in bacterial attachment to sFn, bacteria were heated at 100 
o
C 
for 8 min before they were coated in microtiter plates.  
 
To investigate which regions of antigen I/II were bound to sFn, the following peptides 
were chosen and synthesized (Peptide 2.0, Chantilly, Virginia):  
NAKATYEAALKQYEADLAAVKKANAA (361-386), 
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IETGKKPNIWYSLNGKIRAV (803-822),  
VPKVTKEKPTPPVKPTAPTK (824-843),  
PPVKPTAPTKPTYETEKPLK (834-853),  
ETEKPLEPAPVEPSYEAEPT (925-944),  
PTVHFHYFKLAVQPQVNKEI (985-1004),  
RNNNDINIDRTLVAKQSVVK (1005-1024),  
FQLKTADLPAGRDETTSFVL (1025-1044),  
TLATFNADLTKSVATIYPTV (1085-1104),  
KSVATIYPTVVGGVLNDGAT (1095-1114).  
The peptides were lyophilized at the following purities (following the same order as 
above, in percent): 91.1, 92.2, 96.9, 98.0, 95.1, 96.6, 93.6, 80.6, 79.4, and 93.2, dissolved 
in distilled water to yield 1 mg/ml of solution, and stored at -20 °C. 96-well flat-bottom 
microtiter plates (Costar, Cambridge, MA) were coated with 50 µl of 10 µg/ml of these 
antigen I/II 19-mer peptides. 
 
After washing with PBS three times, each well was blocked with blocking buffer (3% 
bovine serum albumin in PBS-0.05% Tween 20) at 37 °C for 2 hours. After a second 
wash, 50 µl of 10-50 µg/ml Fn (Sigma) was added to each well for 15 min. After another 
wash, 50 µl of 1:1000-10,000 anti-Fn antibodies conjugated with biotin (Rockland, 
Gilbertsville, PA) was added for 1 hour. Then, 50 µl of 1:1,000-3,000 
Streptavidin-Peroxidase (Sigma) was added for another 30 min, followed by washing and 
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o-phenylenediamine (Sigma) color detection. The color change was measured within 30 
min at OD 450 nm.   
 
4.3 Interaction of bacterial surface proteins with sFn in response of CSC  
Far-Western immunoblotting was used to detect the interaction between bacterial surface 
proteins and soluble Fn in response to CSC treatment. S. mutans UA159 cultured with 
CSC (0, 0.25 mg/ml) were harvested until late-log phase. The bacterial surface proteins 
were prepared by the methods mentioned in materials and methods Part 2. The same 
amount of proteins were subjected to electrophoresis and transferred to two 
membranes-A and B. Both were blocked with 3% BSA at 4 °C overnight. Then, 
membrane A was incubated with 1:2,000 anti-S. mutans surface protein antibody (rat 
polyclonal antibody to crude cell surface proteins) for 4 hours, followed by the 
appropriate secondary antibody. Membrane B was incubated with 50 µg/ml of sFn at 
room temperature for 2 hours and followed by extensive washing with PBS. Then, the 
sFn bound to membrane B reacted with anti-Fn antibody (Sigma), which was detected by 
anti-rabbit IgG-peroxidase antibody (Sigma) and visualized by enhanced 
chemiluminescence (ECL; Pierce Chemical Co., Rockford, IL). 
 
4.4 CSC treated bacteria bound to immobilized Fn  
50 µl of 25 µg/ml of Fn was coated in 96-well flat-bottom microtiter plates (Costar, 
Cambridge, MA) at 4 °C overnight. After washing 3 times with PBS, the plate was 
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blocked with blocking buffer (3% bovine serum albumin in PBS-0.05% Tween 20) at 
37 °C for 2 hours and ready for the assay. S. mutans strains UA159, NG8, PC3370 were 
cultured with 0 or 0.25 mg/ml CSC overnight and then labeled with Biotin 
N-hydroxysuccinimide ester (Sigma) as described in the materials and methods Part 2. 50 
µl of labeled bacteria was added to the plate coated with Fn for 15 min. After extensive 
washing 4 times with PBS-0.05% Tween 20, 50 µl of 1:10,000 Streptavidin-Peroxidase 
(Sigma) was added for another 30 min, followed by washing and o-phenylenediamine 
(Sigma) color detection. The color change was measured within 30 min at OD 450 nm.   
 
4.5 Bacterial attachment to HUVECs in response to CSC  
HUVECs at passage number 3 to 9 were collected, washed and resuspended in low-serum 
culture media (0.5%) without Bullet kit® (Lonza, Walkersville, MD) at 5x10
5
 cells per 
ml. 100 µl of the HUVECs suspension with 0 or 50 µg/ml of CSC were seeded in each 
well of a 96-well microtiter plate (Nunc, Fisher). The plate was incubated at 37 °C in a 
humidified 5% CO2 and 95% air incubator overnight. Then, the supernatant was carefully 
removed from each well and 100 µl of methanol (Fisher) was added for 15 min. The 
unoccupied plastic surfaces were blocked with blocking buffer (3% bovine serum 
albumin in PBS-0.05% Tween 20) at 37 °C for 2 hours.  
 
Bacterial strains UA159, NG8 and PC3370 were treated with or without 0.25 mg/ml CSC 
overnight and labeled with biotin as described before. 50 µl of bacterial suspensions in 
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PBS was added to the HUVECs culture plate for 15 min. After extensive washing 4 times 
with PBS-0.05% Tween 20, 50 µl of 1:3,000 Streptavidin-Peroxidase (Sigma) was added 
for another 30 min, followed by washing and o-phenylenediamine (Sigma) color 
detection. The color change was measured within 30 min at OD 450 nm.   
 
4.6 The expression of Fn by HUVECs in response to CSC-immunocytochemistry 
study 
HUVECs treatment 
HUVECs (10
6
) at passage number 3 to 9 were harvested, resuspended in low-serum 
culture media (0.5%) without Bullet kit® (Lonza, Walkersville, MD) and seeded in 
12-well plates (Corning, New York) with glass coverslips. HUVECs were treated with 0, 
25, 50 or 100 µg/ml of CSC overnight. 
 
Immunostaining 
The prepared cells were fixed in 4.0 % paraformaldehyde for 30 min on ice, then blocked 
with 3% BSA at 4 
o
C overnight. After washing 3 times, the cells were incubated with 
1:200 anti-Fn antibodies conjugated with biotin (Rockland, Gilbertsville, PA) at room 
temperature for 4 hours. After another three washes, the cells were incubated with 
FITC-Streptavidin Conjugate (ZyMAX™ Grade) for 1 hour at room temperature and 
washed 3 times with PBS-0.05% Tween 20. Coverslips were mounted with ProLong 
Gold antifade reagent containing 4',6-diamidino-2-phenylindole (DAPI) (Invitrogen), 
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which stains DNA. The expression of Fn by HUVECs treated with different 
concentrations of CSC was observed using fluorescent microscopy.  
 
4.7 Statistical analysis  
All assays were carried out at least three times, with the results presented as the means 
and standard deviations. The analysis of variance (ANOVA) or paired t test was used to 
compare the difference between treated groups and the control group with p<0.05 
designated as being significantly different. 
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RESULTS 
1. The relationship between smoking and tooth loss-epidemiological data analysis  
1.1 The respondents’ characteristics in this analysis  
A total of 314,986 respondents were included in this analysis with 60.85% of females and 
39.15% of males. Among this population, 46.3% of the people had all teeth remaining, 
31.0% had 1-5 teeth removed due to caries or periodontal disease, 14.3% had 6 or more 
(but not edentulous) lost and 8.4% were edentulous.  
 
As indicated in Figure 2, the prevalence of people with all teeth remaining decreased with 
increasing age and the number of teeth removed increased with increasing age. Among 
the group at 65 years or older, 20.95% of people were edentulous and only 21.52% 
people had all teeth remaining. The people with all teeth remaining dramatically 
decreased from 76.74% among the young adults (18-34 years) to 48.52% among the 
middle age group (35-64 years). 
 
The prevalence of the number of teeth removed due to caries and periodontal disease 
across several selected variables including demographic factors, oral health habits, 
general health habits and general health status is presented in Table 1. In this population, 
more women had all of their teeth removed than men (9.0% vs 7.5%). 9.5% of blacks 
were edentulous, which was higher than that of whites (8.5%). The percentage of people 
with all teeth remaining was lower among blacks than among whites (32.5% vs 48.0%). 
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People with a higher education level (college graduate) had more teeth remaining and 
less prevalence of edentulism than those with a lower education level (less than high 
school) (63.4% vs 21.5%; 2.1% vs 25.6%, respectively). The number of teeth removed 
was also closely related to income. The people with higher income had a lower 
percentage of edentulism. For example, only 1.9% of people with income more than 
50,000 USD per year were edentulous, while this number dramatically increased to 
21.5% among the people with less than 15,000 USD per year. Among those who visited 
dentists or dental clinics within 1 year, 51.2% had all teeth remaining, and only 2.6% 
were edentulous. While among those who did not have regular dental check-ups for over 
5 years, only 26.9% had all teeth remaining, 39.0% were edentulous. People with more 
physical activity in their leisure time also had more teeth remaining than those with less 
activity (percentage of people with all teeth remaining was 50.9% vs 32.2%; percentage 
of edentulism was 6.1% vs 15.2%). Non-smokers had a higher percentage with all teeth 
remaining and a lower prevalence of edentulism than smokers, including current and 
former smokers. For example, 55.1% of non-smokers had all teeth remaining; only 5.1% 
were edentulous. However for current regular smokers (smoking every day), only 32.4% 
had all teeth remaining and 13.5% were edentulous. Heavy drinkers that were defined as 
“adult men having more than two drinks per day and adult women having more than one 
drink per day” had a lower prevalence of edentulism than those with light alcohol 
consumption (4.8% vs 8.6%). People with body mass index around 3000 or more (obese) 
had more prevalence of edentulism and less percentage of people with all teeth remaining 
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than those with normal BMI (less than 2500) (edentulous: 9.6% vs 7.7%; with all teeth 
remaining: 38.8% vs 52.7%). Also, people who had been diagnosed with diabetes had a 
higher percentage of edentulism than those without diabetes (18.8% vs 7.2%).  
 
About 14.2% of surveyed adults were regular current smokers who smoked every day, 
4.6% were occasional current smokers who smoked some days, 28.4% were former 
smokers and 52.8% were non-smokers. Figure 3 demonstrated that the prevalence of 
regular current smokers dropped from 17.2% among the young adults group to 7.1% 
among the 65 years or older group. However, the percentage of non-smokers who did not 
smoke at least 100 cigarettes in their entire life also dropped from 61.6% among young 
adults (18-34 years) to 49.2% among elder people (65 years or older).   
 
Among people age 65 or older, almost 40% of current daily smokers were edentulous, 
while only 16% of non-smokers had lost all of their teeth (Table 2). Among the subjects 
aged between 35 to 64 years, the percentage of endentulism was also dramatically higher 
among current daily smokers than non-smokers (12.4% vs 2.2%).  
 
1.2 Relative risks for the association between participants’ demographic factors and 
tooth loss 
The risk of having teeth removed due to caries and periodontal diseases increased with 
increasing age, even after adjustment for other risk factors related to caries or periodontal 
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diseases including gender, race, marital status, education, annual household income, 
smoking status, alcohol consumption, diabetes, body mass index, the last dental visit, and 
leisure activity by using an ordinal logistic regression model (Figure 4). And this 
relationship seemed not to be a linear increase, but was more pronounced among people 
between 35 to 64 years. 
 
Table 3 demonstrates that males were at less risk of having teeth removed due to caries or 
periodontal diseases than their female counterparts with RR of 0.96 (95% CI, 0.94-0.98). 
But this relationship was not significant for people 65 years or older (RR 0.99; 95% CI, 
0.96-1.02). Generally, the relationship between race and the number of teeth lost was also 
statistically significant. Black, Hispanic and other racial groups were at greater risk than 
their White counterparts with RRs of 1.80 (95% CI, 1.75-1.85), 1.07 (95% CI, 1.03-1.10) 
and 1.34 (95% CI, 1.29-1.40), respectively. However, Hispanics age 65 years or older 
seemed to have less risk of having teeth removed than their white counterparts. Social 
economic status like education levels and annual income also were significantly related to 
the number of teeth removed for all age groups. The risk for people with less than a high 
school education was almost three times as many as that for people with a college 
graduate level (95% CI, 2.97-3.16). Also, the risk for people with less than 15,000 USD 
annual household incomes was around 2.5 (95% CI, 2.39-2.54) when compared to those 
with more than 50,000 USD.  
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1.3 Relative risks for the association between the preventable factors and the 
number of teeth lost  
The relationship between smoking status and the number of teeth removed was 
statistically significant in this population (Table 4). Generally, current daily smokers were 
at higher risk of having teeth removed than current occasional smokers or former 
smokers (2.95 vs 1.96 vs 1.64, respectively). This trend remained significant in all three 
age groups. Moreover, the middle aged adults (35-64 years) who were smoking every day 
were at greater risk than the younger (18-34 years) and older (65 years or older) 
counterparts (3.18 vs 2.58 vs 2.59, respectively).  
 
Generally, people who visited a dentist less often were at higher risk of having lost teeth 
(Table 5). This relationship was present in a dose-dependent manner. For example, for 
those who did not visit a dentist or dental clinic within the past 5 years, the risk of having 
teeth removed was as high as 3 (95% CI, 2.93-3.07) and reduced to 1.62 (95% CI, 
1.58-1.67) for those who did not have a dental visit for 2 to 5 years when compared to 
those who did so within past 12 months. This trend remained the same among the 
middle-aged and older adults at age of 65 or older. However, younger adults who visited 
a dental clinic more often seemed at higher risk of losing teeth. Higher body mass index 
was significantly associated with the number of teeth lost in a dose dependent manner. 
For those with a BMI between 2500 and 3000 or more than 3000, the risk of having lost 
teeth was 1.13 (95% CI, 1.11-1.15) and 1.31 (95% CI, 1.29-1.34), respectively, when 
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compared to those with a normal BMI (less than 2500). Diabetes also was a risk factor 
for tooth loss, which was more obvious in the young adult group. For example, the risk 
for younger diabetics (18-34 years) of having lost teeth due to caries or periodontal 
disease was 1.55 (95% of CI, 1.32-1.81), while the corresponding RR for elderly adults 
(65 years or older) was 1.13 (95% of CI, 1.08-1.17). Leisure time physical activity was a 
protective factor for tooth loss with relative risk of 0.82 (95% CI, 0.80-0.83). Alcohol 
consumption was another protective factor for teeth lost in all age groups. People with 
less alcohol consumption were at a greater risk for having lost teeth with relative risk of 
1.34 (95% CI, 1.29-1.38) when compared to those with heavy alcohol consumption. 
 
The population attributable fractions of several preventable risk factors were also 
estimated based on the adjusted RRs and the prevalence of population exposed to the risk 
factors (Table 6). It was clearly demonstrated that among those with one or more teeth 
removed, current daily smoking contributed more than 20%. Also, for almost 19% of 
people loss of one or more teeth was attributed to no dental visit for over 5 years.  
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2. In vitro effect of cigarette smoke condensate (CSC) on the cariogenic virulence 
factors of oral streptococci  
2.1 Effect of CSC on bacterial viability and growth  
The MIC value of CSC was significantly higher for S. mutans (mean MIC 4±0 mg/ml) 
than for S. gordonii (mean MIC 2.5±1 mg/ml) (p=0.024). The mean MBC value against S. 
mutans was also higher than that for S. gordonii which was 7±2 mg/ml and 4±2.8 mg/ml, 
respectively, but without statistical significance (p>0.05). After 8 hours of incubation, S. 
gordonii had more than a 2 log10 drop (99% kill) in viability at concentrations of 4 and 6 
mg/ml, and the reduction reached a margin of a 2 log10 drop at a concentration of 2 
mg/ml. S. mutans did not present a 2 log10 drop in viability after 8 hours at any CSC 
concentration tested (Figure 5).  
 
In addition to the bacteriostatic and bactericidal effects of CSC at higher concentrations, 
CSC also affected the growth of S. mutans and S. gordonii at lower concentrations 
(sub-MIC) in terms of lag phase and doubling times. Generally, CSC delayed bacterial 
growth by prolonging lag phase (Figure 6). The average time for untreated S. mutans and 
S. gordonii to enter log phase was 180±24.5 min and 187.5±15 min, respectively. The 
average lag time needed for S. mutans treated with 0.5 mg/ml CSC was significantly 
increased to 330±42.2 min compared to the no CSC control (p<0.001). As for S. gordonii, 
the mean lag phase time was significantly longer (p<0.05) for bacteria treated with 0.25 
mg/ml and 0.5 mg/ml (300±42.4 min and 465±90 min, respectively) than for the control 
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group of S. gordonii and also for S. mutans treated at the same concentrations. The 
doubling time for S. mutans was significantly increased at concentrations of 0.25 and 0.5 
mg/ml (119.1±28.5 min and 243.7±63.1 min versus 88.6±26.1 min, p<0.05) (Table 7). 
The doubling time for S. gordonii increased at the same concentrations, but there was no 
statistical significance between treated groups and controls.   
 
2.2 Effect of CSC on bacterial sucrose-dependent adherence and dextran-binding  
CSC tended to enhance the sucrose-dependent adherence of S. mutans (Figure 7). In the 
presence of sucrose, the percentage of tightly adherent S. mutans on glass surfaces 
increased from 16.2% of untreated bacteria to 20.6%, 23.1% and 19.0% of those treated 
with 0.0625, 0.125 and 0.25 mg/ml CSC, respectively. The increase reached statistical 
significance at CSC concentrations of 0.125 and 0.25 mg/ml compared to the control 
group. As for S. gordonii, the percentage of tightly adherent bacterial cells was not 
significantly different between the control group and the treated groups.  
 
CSC also significantly enhanced the dextran binding activity of S. mutans (Figure 8). 
Generally, the dextran-binding abilities for the CSC treatment groups were almost twice 
as high as those of the untreated group. The dextran-binding ability of untreated S. 
mutans measured by absorbance at 490 nm was 0.22, which was significantly increased 
to 0.46, 0.40 and 0.47 for S. mutans treated with 0.0625, 0.125 and 0.25 mg/ml CSC, 
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respectively. The dextran binding ability of S. gordonii was not affected in response to 
CSC treatment compared to its own control (Figure 8). 
 
2.3 CSC effects on GTF and GBP expression  
S. mutans significantly increased the production of GTF, GbpA and GbpB in response to 
CSC in a dose dependent manner (Figure 9). The density of the three proteins with CSC 
treatment of 0.25 mg/ml was over 2 to 3 times higher than that of the control group. 
Furthermore, the expression of GTF by S. gordonii was clearly down-regulated in the 
CSC treatment groups, which was only one third of the control group.   
 
2.4 CSC effect on S. mutans sucrose-independent attachment 
Smoking condensate significantly enhanced S. mutans binding ability to the saliva coated 
on 96-well plate, which was increased by 50% for the CSC treated group (Figure 10). The 
expression of antigen I/II by S. mutans was significantly increased in response to CSC 
treatment and in a CSC dose dependent manner (Figure 11).  
 
It was not surprising that antigen I/II played an important role in bacterial attachment to 
saliva. The ELISA assay demonstrated that antigen I/II deficient mutant S. mutans 
(PC3370) had lower binding ability to the saliva coated on 96-well plates than their 
parent strain NG8 (Figure 12). Meanwhile, in response to CSC stimulation the binding 
75 
ability of the wild-type strain NG8 to the saliva significantly increased up to 60%, while 
the binding ability of PC3370 remained the same (p=0.969, paired t-test).  
 
2.5 CSC effects on the acid production of S. mutans 
CSC treatment did not significantly affect the acid production by S. mutans (Figure 13), 
although it seemed that S. mutans treated with lower CSC concentrations around 0.0625 
and 0.125 mg/ml had greater pH reduction after 30 minutes incubation with 1% sucrose 
than the untreated control group. But the statistical analysis was not significant (p>0.05, 
student‟s t-test).  
76 
3. The joint effect of oral health status and smoking on cardiovascular diseases- 
epidemiological analysis  
3.1 The number of teeth removed was an independent risk factor for CVD 
development  
The data analysis included 151,245 adults aged from 35 to 59 years, of whom 3.9% were 
edentulous, 11.0% lost 6 or more teeth but not all, 33.3% had 1 to 5 teeth missing, and 
51.9% had all teeth remaining. Of these respondents, 24.5% were former smokers, 21.9% 
were current smokers (including daily and occasional smokers) and 53.5% were 
non-smokers. 6.0% of them had ever been diagnosed with CVD. The prevalence of CVD 
was higher among current or former smokers than those who never smoked (9.2% vs 
7.6% vs 3.9%, respectively). The prevalence of CVD across several selected variables 
including demographic factors, oral health status and other preventable risk factors also is 
presented in Table 8. Generally, female, White, people with high annual income, high 
education level, regular dental check-up or frequent physical activities had less 
prevalence of CVD. While among the smokers, diabetics, or people with more teeth 
removed or greater BMI, the prevalence of CVD was high.  
 
Figure 14 demonstrates that in all subjects, the prevalence of CVD among those with all 
teeth remaining was only 3.1%, which was dramatically increased to 6.2% among people 
with 1-5 teeth missing, 13.5% among people with 6 or more teeth missing and 21.2% 
among the edentulous. It was also clearly demonstrated that the prevalence of CVD was 
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higher in older age groups, especially among the edentulous. The unadjusted RRs 
demonstrated that the number of teeth lost was associated with CVD in a dose-dependent 
manner (Table 9). In each age group the more lost teeth, the higher risk for the subjects to 
have CVD. This tendency remained significant even after being adjusted for other 
variables like demographic factors, socio-economic status, personal health habits and 
general health status. The risks for people with 1 to 5 teeth removed, 6 or more, and being 
edentulous were 1.37 (95% CI, 1.29-1.45), 2.19 (95% CI, 2.04-2.34) and 2.79 (95% CI, 
2.55-3.04), respectively.  
 
3.2 The relative risks of other preventable factors including smoking for CVD 
development 
As for the smoking status and other preventable risk factors including the frequency of 
dental clinic visits, leisure time activities, alcohol consumption, BMI and diabetes, the 
associations are listed in Table 10. Smokers including current and former smokers were at 
higher risk to have CVD than those who never smoked with a relative risk of 1.54 (95% 
CI, 1.47-1.62). Alcohol consumption appeared to be a protective factor. Generally, people 
with less alcohol consumption were at a greater risk of having CVD with relative risk of 
1.38 (95% CI, 1.23-1.55), when compared to those with heavy alcohol consumption. 
However, this relationship was only significant for people aged at 50 or older. Regular 
dental visits and frequent activities in leisure time were also protective factors for CVD 
with relative risks of 0.79 (95% CI, 0.75-0.83) and 0.71 (95% CI, 0.67-0.74), respectively. 
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Diabetics have a higher risk of having CVD than non-diabetics with a relative risk of 2.66 
(95% CI, 2.51-2.82), which was significant for all age groups. People with greater body 
mass index were more likely to have CVD than those with normal body mass index. For 
example, the risks for the overweight and the obese of having CVD were 1.16 (95% CI, 
1.09-1.23) and 1.53 (95% CI, 1.14-1.63), respectively. But, the association between being 
overweight and CVD was only significant for people age 50 years or older. 
 
3.3 The joint effect of the number of teeth removed and smoking on CVD 
To eliminate the residual confounding effect of smoking on the association between the 
number of teeth lost and CVD, the association was then analyzed by stratifying the 
smoking status among this population (Table 11). Among non-smokers, or former 
smokers or current smokers, the number of teeth lost was consistently and significantly 
related to CVD, also in a dose-dependent manner. For example, among the non-smokers, 
when compared to those with all teeth remaining, people with 1-5 teeth missing, 6 or 
more teeth missing, and all teeth missing were at 1.37 risk (95% CI, 1.26-1.50), 2.02 
(95% CI, 1.79-2.28) and 2.72 (95% CI, 2.27-3.26) of having CVD, respectively. Among 
current smokers, when compared to those with all teeth remaining, people with 1-5 teeth 
missing, 6 or more teeth missing, and all teeth missing were at 1.28 risk (95% CI, 
1.14-1.44), 2.09 (95% CI, 1.86-2.36) and 2.54 (95% CI, 2.21-2.91) of having CVD, 
respectively. 
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To detect the combined effect of age and the number of teeth missing on CVD, the 
relationship between tooth loss and CVD was analyzed only for smokers (including 
current and former smokers) and stratified within the 5 age groups (Table 12). This 
relationship was stronger among younger people. The risks of edentulous smokers of 
having CVD significantly decreased from 5.02 (95% of CI, 2.87-8.81) among the 35-39 
age group to 2.51 (95% CI, 2.14-2.94) among the 54-59 age group. 
 
To further elucidate the interaction of the effect of smoking and tooth loss on CVD, a new 
interaction variable (the number of teeth missing * smoking status) was created and the 
relative risks of the interaction variable for different age groups are presented in Figure 
15. Overall, different age groups presented different interaction patterns. The joint effect 
of smoking and being edentulous seemed attenuated in the eldest group (55-59), when 
compared to the younger age group such as 40-44 or younger. In the youngest age group 
(35-39), the interaction pattern was more complicated. Among people who lost 6 or more 
teeth (but not all), the never smokers were at slightly higher risk of having CVD than 
ever smokers (3.61 vs 3.02). The risk for edentulous smokers dramatically increased to 
7.03, while the risk for edentulous non-smokers almost remained at the same level as 
non-smokers with 6 or more teeth missing.  
 
The additive interaction between smoking status and the number of teeth missing was 
presented for different age groups in Figure 16 and Table 13. There was no significant 
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joint effect between smoking and losing only 1 to 5 teeth on the additive scale for all age 
groups. In the youngest group (35-39 years), the only significant interaction effect was 
observed between being edentulous and smoking, but the attributable proportion due to 
the interaction (AP) was as high as 0.47, which indicates that the combined effect of 
missing all teeth and smoking contributes to at least 47% of CVD among this age 
population. The joint effect between losing 6 teeth or more (including edentulous) and 
smoking was higher among younger age groups (between 40 to 49 years) and slightly 
decreased in the eldest group (50-59 years), but remained statistically significant with AP 
ranging from 0.15 to 0.23. 
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4. In vitro effect of cigarette smoke condensate on S. mutans attachment to 
fibronectin and HUVECs 
4.1 Smoking condensate enhanced S. mutans binding ability to both soluble and 
immobilized fibronectin  
The far western assay in which S. mutans (UA159) was incubated with different 
concentrations of sFn (6 or 16 µg /ml) confirmed that S. mutans was able to bind to 
soluble Fn in a Fn dose-dependent manner (Figure 17). Moreover, CSC (0.25 mg/ml) 
enhanced this binding ability. Our ELISA data confirmed this enhanced bacterial 
attachment (Figure 18), in which the binding ability was significantly increased by 14% 
for the CSC-treated group (paired t-test, p<0.05). Moreover, it was also demonstrated that 
bacterial surface proteins played an important role in bacterial attachment to sFn. That is, 
the heat-treated bacteria had significantly reduced binding ability to sFn, especially for 
the CSC-treated group with 63% reduction of binding when compared to its own 
unheated control group.  
 
The far western data demonstrated that at least 9 different bacterial surface proteins were 
able to bind to sFn and most of these proteins had increased binding ability in response to 
CSC treatment (Figure 19). The far western blot also documented that several surface 
proteins (Figure 19A) with similar molecular weights as those bound to sFn (Figure 19B) 
had increased production in response to the CSC treatment.   
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CSC (0.25 mg/ml) also significantly increased S. mutans attachment to immobilized Fn 
by over 20%, when compared to the untreated control (Figure 20).  
 
4.2 Smoking condensate enhanced S. mutans attachment to HUVECs  
The attachment assay (ELISA) was conducted for S. mutans (UA159) and HUVECs in 
response to CSC treatment. It was found that for bacteria treated with 0.25 mg/ml of CSC, 
bacterial attachment to untreated HUVECs was significantly increased over 100%, when 
compared to the untreated bacterial attachment to untreated HUVECs (Figure 21). 
However, the amount of untreated bacteria attached to the treated HUVECs was 
increased only 40%. The amount of treated bacteria attached to the CSC treated (50 
µg/ml) HUVECs also increased almost 92%.   
 
The immunocytochemistry study illustrated that the production of cell associated Fn by 
HUVECs was increased in response to CSC treatment (Figure 22).   
 
4.3 Antigen I/II is important for S. mutans attachment to Fn and HUVECs  
The role of antigen I/II in bacterial attachment to both soluble and immobilized Fn was 
investigated for S. mutans treated with CSC. Figure 23 illustrates that the untreated 
antigen I/II-deficient strain PC3370 had lower binding ability to sFn than the wild-type 
counterpart NG8. The binding ability was reduced about 22% (p<0.05, paired t-test). 
Although the PC3370 increased binding to sFn by 24% in response to CSC treatment 
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when compared to the untreated PC3370, the binding ability was still lower than the 
treated NG8 by 13% (p<0.05, paired t-test). Both wild-type and antigen I/II-deficient 
strains had enhanced binding ability to immobilized Fn in response to CSC treatment 
(p<0.05) (Figure 24). However, the untreated PC3370 had only 62.7% of binding ability 
of NG8 (p<0.05). Moreover, the binding ability of the treated PC3370 was still lower 
than that of treated NG8 by 24.2%. (p<0.05). 
 
The antigen I/II 19 mer peptides assay demonstrated that the region between the P-region 
and the wall and membrane spanning regions was responsible for attachment to sFn 
(Figure 25). That is, the lowest binding sites were a peptide in the A region with amino 
acid sequence between 361-386 and some peptides between the V-region and P-region 
with amino acid sequences between 824-853. The highest Fn binding sites were found in 
the regions with amino acid sequences around 1005-1044 and 1095-1114.  
 
Antigen I/II also played an important role in S. mutans attachment to HUVECs without 
CSC treatment (Figure 26). In the absence of CSC treatment for both bacteria and 
HUVECs, PC3370 had only 52.1% binding ability of their counterparts in NG8 group. 
However, with the CSC treatment for either S. mutans or HUVECs or both, the amount of 
bacterial attachment significantly increased for the PC3370 strain (p<0.05, one-way 
ANOVA, LSD test), but not for NG8 (p>0.05, one-way ANOVA, LSD test). When 
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PC3370 and HUVECs were both treated with CSC, the amount of bacteria attached to 
HUVECs was similar to that of NG8. .  
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TABLES  
Table 1. Distribution of the number of permanent teeth lost in the BRFSS study population by 
selected variables 
 
The number of teeth removed* 
All teeth 
remaining 
1 to 5 6 or more Edentulous 
Gender 
Male 
57747 39399 17254 9251 
 46.7% 31.9% 14.0% 7.5% 
 
Female 
88390 58505 27978 17220 
 46.0% 30.5% 14.6% 9.0% 
Race 
White 
119370 73772 34315 21084 
 48.0% 29.7% 13.8% 8.5% 
 
Black 
8112 9224 5240 2374 
 32.5% 37.0% 21.0% 9.5% 
 
Hispanic 
9935 8457 2725 1263 
 44.4% 37.8% 12.2% 5.6% 
 
Other race 
5588 3950 1489 862 
 47.0% 33.2% 12.5% 7.3% 
 
Multiracial 
2223 1777 1021 528 
 40.1% 32.0% 18.4% 9.5% 
Age 
18-24 
11850 2002 129 26 
 84.6% 14.3% .9% .2% 
 
25-29 
12687 3568 345 55 
 76.2% 21.4% 2.1% .3% 
 
30-34 
15316 5202 621 124 
 72.0% 24.5% 2.9% .6% 
 
35-39 
17550 7008 1146 232 
 67.7% 27.0% 4.4% .9% 
 
40-44 
17741 8960 2030 536 
 60.6% 30.6% 6.9% 1.8% 
 
45-49 
16739 11185 3440 1002 
 51.7% 34.6% 10.6% 3.1% 
 50-54 15578 12073 4790 1683 
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 45.7% 35.4% 14.0% 4.9% 
 
55-59 
12735 12523 5815 2642 
 37.8% 37.1% 17.2% 7.8% 
 
60-64 
8628 9895 6127 3384 
 30.8% 35.3% 21.9% 12.1% 
 
65-69 
5875 7964 5991 4102 
 24.5% 33.3% 25.0% 17.1% 
 
70-74 
4310 6391 5233 4137 
 21.5% 31.8% 26.1% 20.6% 
 
75-79 
3364 5291 4498 3840 
 19.8% 31.1% 26.5% 22.6% 
 
80 or older 
3764 5842 5067 4708 
 19.4% 30.1% 26.1% 24.3% 
Education 
level 
Not graduate high 
school 
6646 8794 7600 7938 
21.5% 28.4% 24.5% 25.6% 
High school 
32655 32669 18131 11130 
34.5% 34.5% 19.2% 11.8% 
Attend college 
39362 27445 11514 5184 
47.1% 32.9% 13.8% 6.2% 
Graduate college 
67159 28748 7796 2215 
63.4% 27.1% 7.4% 2.1% 
Income                       
(USD) 
Income < 15,000 
7618 9308 8305 6926 
23.7% 28.9% 25.8% 21.5% 
15,000 <= 
income < 25,000 
14609 15630 10177 7117 
30.7% 32.9% 21.4% 15.0% 
25,000 <=
income < 35,000 
13917 12639 6316 3328 
38.4% 34.9% 17.4% 9.2% 
35,000 <= 
income < 50,000 
21666 15810 6187 2387 
47.0% 34.3% 13.4% 5.2% 
Income >= 
50,000 
73201 33157 8254 2245 
62.6% 28.4% 7.1% 1.9% 
Last time 
visit dentist 
or dental 
Within 1 year 
110712 72004 27711 5511 
51.3% 33.3% 12.8% 2.6% 
Between 1-2 14170 10967 5973 2583 
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clinic years 42.1% 32.5% 17.7% 7.7% 
Between 2 to 5 
years 
10356 8104 5289 3798 
37.6% 29.4% 19.2% 13.8% 
More than 5 years 
9680 6334 5943 14060 
26.9% 17.6% 16.5% 39.0% 
Leisure time 
physical 
activity 
Yes 
120972 72948 29063 14606 
50.9% 30.7% 12.2% 6.1% 
No 
25165 24956 16169 11865 
32.2% 31.9% 20.7% 15.2% 
Smoking 
status 
Current smoker 
every day 
14523 14880 9426 6051 
32.4% 33.2% 21.0% 13.5% 
Current smoker, 
some days 
6307 4584 2137 1380 
43.8% 31.8% 14.8% 9.6% 
Former smoker 
33395 29034 16744 10546 
37.2% 32.4% 18.7% 11.8% 
Non-smoker 
91888 49380 16913 8490 
55.1% 29.6% 10.1% 5.1% 
Heavy 
alcohol 
consumption 
No 
138275 93655 43332 25766 
45.9% 31.1% 14.4% 8.6% 
Yes 
7862 4249 1900 705 
53.4% 28.9% 12.9% 4.8% 
Body mass 
index 
Normal (BMI < 
2500) 
62062 32738 13875 9125 
52.7% 27.8% 11.8% 7.7% 
Overweight                              
(2500 <= BMI < 
3000) 
52003 37191 16708 9459 
45.1% 32.2% 14.5% 8.2% 
Obese (BMI >= 
3000) 
32072 27975 14649 7887 
38.8% 33.9% 17.7% 9.6% 
If have 
diabetes 
Yes 
7439 9878 8048 5872 
23.8% 31.6% 25.8% 18.8% 
No 
138698 88026 37184 20599 
48.8% 30.9% 13.1% 7.2% 
* All the p-values for these categorical variables were less than 0.05 (not shown due to space 
limitations, X2 test).   
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Table 2. The prevalence of the number of teeth removed due to caries or periodontal diseases 
stratified by smoking status and age groups in the BRFSS study population 
    
All teeth 
remaining 1 to 5 6 or more Edentulous 
18-34 
Current smoker every day 61.2% 31.6% 6.2% 1.1% 
Current smoker some days 72.9% 24.4% 2.4% 0.3% 
Former smoker  76.1% 21.7% 1.9% 0.4% 
Non-smoker  81.7% 17.1% 1.0% 0.2% 
35-64 
Current smoker every day 27.8% 36.1% 23.7% 12.4% 
Current smoker some days 37.7% 36.3% 17.2% 8.8% 
Former smoker  43.8% 35.8% 14.6% 5.9% 
Non-smoker  58.6% 31.4% 7.8% 2.2% 
65 or 
older 
Current smoker every day 11.2% 20.0% 29.7% 39.1% 
Current smoker some days 14.3% 24.0% 28.6% 33.1% 
Former smoker  19.1% 29.7% 28.3% 22.9% 
 Non-smoker  25.4% 35.5% 23.0% 16.2% 
Current smoker some days was defined as people who were smoking occasionally. 
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Table 3. Multivariable-adjusted RRs with 95% CI for the association between demographic 
characteristics and the number of teeth removed stratified by 3 age groups in the BRFSS study 
population 
 All  18-34 years 35-64 years 
65 years or 
older 
Gender (Female group as the reference)   
Male 
0.96              
(0.94-0.98) 
0.87             
(0.83-0.92) 
0.97           
(0.95-0.99) 
0.99        
(0.96-1.02) 
Race (White group as the reference)    
Black 
1.80              
(1.75-1.85) 
1.87                
(1.74-2.01) 
1.91           
(1.84-1.97) 
1.40        
(1.31-1.49) 
Hispanic 
1.07              
(1.03-1.10) 
1.33             
(1.24-1.43) 
1.05          
(1.01-1.10) 
0.88       
(0.81-0.94) 
Other race 
1.34             
(1.29-1.40) 
1.55             
(1.40-1.71) 
1.41           
(1.34-1.49) 
1.02        
(0.92-1.12) 
Multiracial 
1.32              
(1.25-1.40) 
1.49              
(1.29-1.73) 
1.37           
(1.28-1.47) 
1.19        
(1.06-1.34) 
Education (people with graduate school education as the reference)  
Less than high 
school 
3.06              
(2.97-3.16) 
3.60              
(3.28-3.95) 
3.43           
(3.28-3.58) 
2.17         
(2.05-2.29) 
High school 
2.18              
(2.13-2.23) 
2.51              
(2.34-2.68) 
2.33           
(2.27-2.39) 
1.70        
(1.63-1.78) 
Attend college 
1.59              
(1.55-1.62) 
1.79             
(1.68-1.91) 
1.62           
(1.57-1.66) 
1.38        
(1.32-1.44) 
Income (people with household annual income more than 50,000 USD as the reference) 
Less than 15,000 
2.46              
(2.39-2.54) 
2.53              
(2.31-2.76) 
2.70           
(2.60-2.82) 
2.03        
(1.92-2.16) 
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15,000-25,000 
1.97             
(1.92-2.02) 
2.16             
(2.01-2.33) 
2.15           
(2.08-2.22) 
1.70        
(1.62-1.79) 
25,000-35,000 
1.62              
(1.58-1.67) 
1.74              
(1.62-1.88) 
1.70           
(1.64-1.76) 
1.48       
(1.41-1.56) 
35,000-50,000 
1.37              
(1.34-1.40) 
1.44              
(1.35-1.55) 
1.36           
(1.40-1.44) 
1.29       
(1.23-1.36) 
Marital status (unmarried people as the reference)   
Married 
1.05              
(1.03-1.07) 
1.16               
(1.10-1.22) 
1.07            
(1.05-1.10) 
0.99        
(1.02-0.96) 
RRs were adjusted for gender, race, age, marital status, education, annual household income, 
smoking status, alcohol consumption, diabetes and body mass index, if visited a dentist within the 
past year, and leisure activity by using an ordinal logistic regression model.  
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Table 4. Multivariable-adjusted RRs with 95% CI for the association between smoking status and 
the number of teeth lost stratified by 3 age groups (non-smokers as reference) in the BRFSS study 
population 
 All 18-34 35-64 65 or older 
Current smoker 
every day 
2.95                  
(2.87-3.01) 
2.58           
(2.43-2.74) 
3.18             
(3.09-3.27) 
2.59            
(2.43-2.75) 
Current smoker 
some days 
1.96                  
(1.89-2.03) 
1.53           
(1.40-1.68) 
2.06             
(1.97-2.15) 
2.06             
(1.87-2.28) 
Former smoker 
1.64                   
(1.61-1.67) 
1.40          
(1.31-1.50) 
1.61            
(1.57-1.65) 
1.68             
(1.62-1.73) 
RRs were adjusted for gender, race, age, marital status, education, annual household income, 
alcohol consumption, diabetes and body mass index, if visited a dentist within past year, and 
leisure activity by ordinal logistic regression model.  
92 
Table 5. Multivariable-adjusted RRs with 95% CI for the association between other preventable 
factors and the number of teeth lost stratified by 3 age groups in the BRFSS study population 
 all  18-34 35-64 65 or older 
Last visited dentist or dental clinic (within the past year as the reference) 
1-2 years 
1.41                           
(1.38-1.45) 
0.96           
(0.90-1.03) 
1.34                  
(1.30-1.38) 
1.90                  
(1.80-2.00) 
2-5 years 
1.62                    
(1.58-1.67) 
0.77                  
(0.72-0.83) 
1.50                  
(1.45-1.55) 
2.91                  
(2.75-3.07) 
> 5 years 
3.00                    
(2.93-3.07) 
0.42                  
(0.38-0.46) 
2.05                  
(1.99-2.13) 
10.71               
(10.23-11.21) 
Leisure time physical activity (no physical activity or exercise in last 30 days as the reference) 
 
0.82                    
(0.80-0.83) 
0.81                   
(0.77-0.86) 
0.80                 
(0.78-0.82) 
0.88                  
(0.85-0.91) 
Body Mass Index (people with normal weight as the reference) 
Overweight 
(2500 <= BMI < 3000) 
1.13                    
(1.11-1.15) 
1.02                  
(0.96-1.07) 
1.17                  
(1.14-1.19) 
1.12                  
(1.08-1.16) 
Obese 
(BMI >= 3000) 
1.31                    
(1.29-1.34) 
1.22                  
(1.15-1.29) 
1.38                   
(1.35-1.42) 
1.22                    
(1.17-1.28) 
If have been diagnosed with diabetes (non-diabetes as the reference) 
 
1.29                    
(1.26-1.33) 
1.55                  
(1.32-1.81) 
1.39                  
(1.34-1.44) 
1.13                  
(1.08-1.17) 
Heavy alcohol consumption (heavy drinkers as the reference) 
 
1.34                    
(1.29-1.38) 
1.20                  
(1.08-1.33) 
1.31                  
(1.25-1.37) 
1.40                  
(1.29-1.52) 
RRs were adjusted for gender, race, age, marital status, education, annual household income, 
alcohol consumption, diabetes and body mass index, if visited a dentist within past year, and 
leisure activity by ordinal logistic regression model.  
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Table 6. The population attributable fraction of several preventable risk factors for tooth loss 
stratified by 3 age groups in the BRFSS study population  
 All 18-34 35-64  65 or older 
Smoking status*     
Current smoker every day 21.7% 21.5% 26.5% 10.1% 
Current smoker some days 4.2% 3.6% 4.9% 2.3% 
Former smoker 15.4% 5.3% 14.1% 22.0% 
Last visited dentist or dental clinic     
1-2 years 4.2% NA 3.7% 7.3% 
2-5 years 5.1% NA 4.1% 13.4% 
> 5 years 19.4% NA 9.3% 64.9% 
Body Mass Index      
Overweight 4.5% 0.6% 5.9% 4.5% 
Obese 7.5% 4.7% 9.9% 4.7% 
If have been diagnosed with diabetes     
Yes 2.8% 0.8% 3.4% 2.2% 
 
*Current smoker some days was defined as people who were smoking occasionally. 
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Table 7. Effect of CSC on the growth of S. mutans and S. gordonii in terms of the doubling time  
 Concentration of CSC (mg/ml) 
 0 0.0625 0.125 0.25     0.5 
S. mutans  
(min.; mean ± SD) 
88.61±26.07 63.70±15.26 61.66±14.28 119.08±28.53* 243.66±63.10* 
S. gordonii 
(min.; mean ± SD) 
93.15±25.26 91.02±19.32 72.12±9.96 119.32±27.16 157.16±60.42 
*Asterisk indicates significant difference (p<0.05; one-way ANOVA LSD test) between the 
indicated value and the control group. 
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Table 8. The prevalence of CVD in the study population by the selected variables (%) and 
stratified by 5 age groups among U.S. middle-aged adults, BRFSS, 2006 
 All       35-39  40-44  45-49  50-54  55-59  
Gender 
Male 7.1% 1.8%* 3.3% 5.3% 8.7% 14.3% 
Female 5.2% 2.0% 2.9% 4.6% 6.4% 9.0% 
Race 
White 5.5% 1.7% 2.7% 4.4% 6.6% 10.4% 
Black 8.1% 2.6% 4.0% 6.8% 11.3% 15.1% 
Hispanic 6.6% 3.2% 4.0% 5.5% 9.4% 13.6% 
Other race 8.2% 2.3% 4.8% 8.2% 10.5% 16.3% 
Education level 
Not gradate high school 13.8% 4.6% 8.2% 11.7% 17.3% 23.3% 
High school 7.4% 2.8% 3.8% 6.1% 8.9% 13.5% 
Attend college 6.2% 1.9% 3.1% 5.1% 7.7% 11.7% 
Graduate college 3.5% 1.2% 1.7% 2.5% 4.3% 7.1% 
Income (USD) 
Less than 25,000 13.0% 4.7% 7.5% 11.6% 16.3% 20.8% 
Between 25,000 and 50,000 5.5% 1.9% 2.9% 4.8% 6.3% 10.5% 
More than 50,000 3.4% 1.0% 1.6% 2.4% 4.4% 7.3% 
The number of teeth removed due to caries or gum diseases 
All teeth remaining 3.1% 1.3% 1.9% 2.7% 4.1% 6.5% 
1 to 5 teeth removed 6.2% 2.8% 3.5% 5.2% 7.4% 9.7% 
6 or more 13.5% 5.5% 8.8% 11.3% 13.6% 18.0% 
Edentulous 21.2% 10.0% 12.7% 16.4% 20.1% 26.4% 
Last time visit dentist or dental clinic 
Within 1 year 4.7% 1.6% 2.4% 3.7% 5.9% 8.8% 
More than 1 year 9.4% 2.9% 4.8% 8.0% 11.5% 17.5% 
Smoking status 
Current smoker 9.2% 3.1% 5.7% 8.0% 11.4% 16.9% 
Former smoker 7.6% 2.0% 3.3% 5.4% 8.4% 13.0% 
Non-smoker 3.9% 1.6% 2.0% 3.1% 4.9% 7.7% 
Leisure time physical activity 
Yes 4.7% 1.7% 2.4% 3.9% 5.8% 9.1% 
No 10.3% 3.2% 5.7% 8.1% 12.5% 17.5% 
Heavy alcohol consumption 
No 6.1% 1.6%* 3.1%* 4.9%* 7.4% 11.4% 
Yes 4.4% 2.0% 3.1% 3.9% 5.5% 6.9% 
Body mass index 
Normal (less than 2,500) 3.9% 1.4% 2.3% 3.5% 4.8% 7.5% 
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Overweight (between 2,500-3,000) 5.4% 1.9% 2.7% 4.1% 6.7% 10.1% 
Obese (more than 3,000) 9.1% 2.9% 4.6% 7.5% 10.9% 16.3% 
If have diabetes 
Yes 19.9% 7.2% 11.2% 15.8% 20.8% 26.4% 
No 4.8% 1.8% 2.7% 4.1% 6.8% 9.0% 
Most of the p-values for these categorical variables were less than 0.05, unless indicated with *.   
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Table 9. The unadjusted and adjusted relative risks with 95% CI for the association of the number 
of teeth removed with CVD stratified by age groups among U.S. middle-aged adults, BRFSS, 
2006 
 All subjects 35-39 40-44 45-49 50-54 55-59 
Unadjusted       
1 to 5  
2.07 
(1.96-2.19) 
2.25 
(1.85-2.74) 
1.88 
(1.60-2.20) 
2.015 
(1.77-2.29) 
1.88 
(1.69-2.09) 
1.53 
(1.39-1.68) 
6 or more 
4.91 
(4.62-5.21) 
4.50 
(3.37-6.02) 
4.91 
(4.06-5.94) 
4.66 
(4.03-5.38) 
3.70 
(3.29-4.16) 
3.15 
(2.85-3.47) 
Edentulous 
8.44 
(7.83-9.09) 
8.54 
(5.39-13.53) 
7.45 
(5.62-9.87) 
7.17 
(5.89-8.72) 
5.92 
(5.11-6.85) 
5.13 
(4.58-5.75) 
Adjusted       
1 to 5 
1.37 
(1.29-1.45) 
1.63 
(1.32-2.01) 
1.34         
(1.14-1.59) 
1.46 
(1.28-1.67) 
1.41         
(1.26-1.57) 
1.20         
(1.09-1.32) 
6 or more 
2.19 
(2.04-2.34) 
2.59 
(1.89-3.55) 
2.54         
(2.06-3.13) 
2.51 
(2.14-2.94) 
2.05         
(1.81-2.34) 
1.93         
(1.73-2.15) 
Edentulous 
2.79 
(2.55-3.04) 
4.50 
(2.76-7.35) 
3.26         
(2.39-4.44) 
3.33 
(2.68-4.13) 
2.61         
(2.21-3.09) 
2.48        
(2.17-2.84) 
People with all teeth remaining were the reference group. 
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Table 10. Adjusted relative risks and 95% CI for the association of the smoking status and other 
preventable factors with CVD stratified by age groups among U.S. middle-aged adults, BRFSS, 
2006 
 
All subjects 35-39 40-44 45-49 50-54 55-59 
Smoking status 
a
 
Ever smokers 
1.54  
(1.47-1.62) 
1.21  
(0.99-1.46) 
1.71  
(1.47-1.99) 
1.53  
(1.36-1.73) 
1.58  
(1.44-1.74) 
1.48  
(1.37-1.60) 
Heavy alcohol consumption 
b  
No 
1.38  
(1.23-1.55) 
1.34  
(0.84-2.15) 
1.03  
(0.76-1.39) 
1.27  
(0.99-1.63) 
1.36  
(1.09-1.69) 
1.67  
(1.35-2.05) 
Visit a dentist or dental clinic within last 12 months 
c
 
Yes 
0.79  
(0.75-0.83) 
0.77  
(0.64-0.94) 
0.81  
(0.70-0.94) 
0.73  
(0.65-0.82) 
0.82  
(0.75-0.90) 
0.79  
(0.72-0.85) 
Have physical activity in leisure time 
d
 
Yes 
0.71  
(0.67-0.74) 
0.81  
(0.66-0.99) 
0.66  
(0.57-0.76) 
0.76  
(0.68-0.86) 
0.68  
(0.62-0.75) 
0.70  
(0.65-0.76) 
Diabetics 
e
 
Yes 
2.66  
(2.51-2.82) 
2.77  
(2.06-3.72) 
2.95  
(2.42-3.60) 
2.87  
(2.49-3.31) 
2.65  
(2.37-2.95) 
2.53  
(2.32-2.76) 
Body mass index 
f
 
Overweight 
(2,500 <= BMI < 3,000) 
1.16  
(1.09-1.23) 
1.25  
(0.99-1.58) 
1.11  
(0.92-1.32) 
1.08  
(0.94-1.24) 
1.20  
(1.07-1.35) 
1.19  
(1.08-1.32) 
Obese 
(BMI>=3,000) 
1.53  
(1.14-1.62) 
1.47  
(1.16-1.86) 
1.42  
(1.19-1.69) 
1.47  
(1.28-1.69) 
1.59  
(1.41-1.78) 
1.57  
(1.43-1.74) 
a. Never smokers were the reference group. 
b. Heavy drinkers were the reference group (the definition of heavy drinkers: adult men having 
more than two drinks per day and adult women having more than one drink per day). 
c. People who did not visit a dentist or dental clinic within the past year were the reference 
group. 
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d. People who did not have physical activity or excising during the past 30 days were the 
reference group. 
e. Non-diabetics were the reference group. 
f. People with normal BMI (less than 2,500) were the reference group. 
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Table 11. Adjusted relative risks and 95% CI for the association of the number of teeth lost with 
CVD stratified by smoking status among U.S. middle-aged adults, BRFSS, 2006 
 missing 1-5 teeth       
RR (95% CI) 
missing 6 teeth or more 
RR (95% CI) 
Edentulous                
RR (95% CI) 
Non-smokers
 1.37  
(1.26-1.50) 
2.02  
(1.79-2.28) 
2.72  
(2.27-3.26) 
Former smokers 
1.35  
(1.22-1.50) 
2.19  
(1.94-2.48) 
2.91  
(2.47-3.41) 
Current smokers
 1.28  
(1.14-1.44) 
2.09  
(1.86-2.36) 
2.54  
(2.21-2.91) 
RRs were adjusted for gender, race, age, marital status, education, the number of teeth removed, 
alcohol consumption, diabetes and body mass index, if visited a dentist within the past year, and 
leisure activity.  
Subjects with all teeth remaining were the reference group.  
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Table 12. Adjusted relative risks and 95% CI for the effect of the number of teeth missing on the 
risk of CVD among smokers stratified by age groups 
  
35-39a          
RR (95% CI) 
40-44a          
RR (95% CI) 
45-49a          
RR (95% CI) 
50-54a          
RR (95% CI) 
55-59a          
RR (95% CI) 
1 to 5b 
1.79             
(1.32-2.42) 
1.45              
(1.17-1.81) 
1.39             
(1.17-1.66) 
1.34              
(1.16-1.56) 
1.19             
(1.05-1.36) 
6 or moreb 
2.38             
(1.56-3.64) 
2.84             
(2.21-3.66) 
2.46             
(2.03-2.98) 
2.00             
(1.70-2.34) 
2.02             
(1.76-2.31) 
Edentulousb 
5.02             
(2.87-8.81) 
3.66             
(2.58-5.20) 
3.10             
(2.42-3.97) 
2.51             
(2.07-3.06) 
2.51              
(2.14-2.94) 
a. RRs were adjusted for gender, race, marital status, education, the number of tooth removed, 
alcohol consumption, diabetes and body mass index, if visited a dentist within the past year, and 
leisure activity.  
b. Subjects with all teeth remained were the reference group. 
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Table 13. Relative excess risk due to interaction (RERI) between smoking status and the number 
of teeth missing among different age groups of American middle-aged adults with 95% CI of 
RERI and attributable proportion due to interaction (AP)  
 All subjects 35-39 40-44 45-49 50-54 55-59 
1 to 5 teeth removed 
RERI        
(95% CI) 
0.27     
(0.07, 0.52) 
0.41               
(-0.22, 1.30) 
0.45               
(-0.05, 1.15) 
0.24               
(-0.18, 0.81) 
0.21               
(-0.10, 0.64) 
0.10               
(-0.13, 0.41) 
AP 0.09  0.14  0.15  0.08  0.08  0.05  
6 or more teeth removed 
RERI        
(95% CI) 
1.25     
(0.84, 1.77) 
-1.67               
(-3,77, 0.95)        
2.18        
(0.84, 3.99) 
1.11         
(0.17, 2.36) 
0.63        
(0.06, 1.40) 
0.91        
(0.56, 1.38) 
AP 0.20  -0.38  0.32  0.18  0.13  0.23  
Edentulous 
RERI        
(95% CI) 
1.77     
(0.84, 2.83) 
4.61         
(0.11, 11.16) 
4.74         
(1.92, 8.47) 
0.19               
(-2.19, 3.03) 
1.02               
(-0.19, 2.5) 
0.81         
(0.15, 1.64) 
AP 0.19  0.47 0.48 0.02 0.15 0.15 
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FIGURES 
 
 
Figure 1. Structural organization of antigen I/II proteins expressed in heterologous hosts.  
The A-region is an alanine-rich domain, containing three 82 residue repeats (A1, A2 and A3). The 
P-region is proline-rich and contains three 39 residue repeats (P1, P2 and P3). The V-region 
(variable region) exhibits some variability among the antigen I/II family. The lower number 
indicats the amino acid sequence. (SspA and SspB are expressed by S. gordonii. PAc and SpaPG 
are expressed by S. mutans. SpaPI is a truncated protein lacking part of the C domain and the wall 
anchor (WA). Pas is expressed by S. intermedius.) The illustration was from reference (96).  
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Figure 2. The percentage of population grouped by the number of teeth removed due to caries or 
periodontal diseases across the three age groups. 
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Figure 3. The percentage of people classified by their smoking status across the three age groups.  
Currently smoking some days were those who were smoking currently but occasionally. 
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Figure 4. The relative risk for the association among the age groups (in five-year age increments) 
and the number of teeth lost.  
RRs were adjusted for gender, race, marital status, education, annual household income, smoking 
status, alcohol consumption, diabetes and body mass index, the last dental visit, and leisure 
activity by using an ordinal logistic regression model. 
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B. S. gordonii
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Figure 5. Time-kill curve expressed in terms of change of mean Log10 CFU/ ml of S. mutans and 
S. gordonii over 8 hours with different concentrations of CSC.  
Data were expressed as the mean ± SD log10 CFU/ml recovered on TSA agar at each time point.  
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Figure 6. Effect of CSC on the growth of S. mutans and S. gordonii in terms of the length of the 
lag phase. 
CSC delayed bacterial growth by prolonging lag phase expressed as the mean ± SD. The average 
lag time for S. mutans treated with 0.5 mg/ml CSC, and S. gordonii treated with 0.25 mg/ml and 
0.5 mg/ml was significantly increased, when compared to the no CSC control (*p<0.05; one-way 
ANOVA, LSD test). 
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Figure 7. Sucrose-dependent adhesion of S. mutans and S. gordonii treated with and without CSC.  
The percentage of tightly adherent bacterial cells of S. mutans were significantly higher in the 
treatment groups at concentrations of 0.125 and 0.25 mg/ml (expressed as the mean ± SD of the 
percentage of tightly adherent cells; *p<0.05; paired t-test).  
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Figure 8. Dextran-binding assay of S. mutans and S. gordonii treated with and without CSC.  
There was a statistically significant difference between treated groups and the untreated group for 
S. mutans (expressed as the mean ± SD of the OD value; one-way ANOVA LSD test; *p<0.05).  
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Figure 9. The expression of glucan binding proteins by S. mutans and S. gordonii.  
GTF, GBPA and GBPB of S. mutans were upregulated in response to CSC in a dose-dependent 
manner, while the expression of GTF by S. gordonii was downregulated. (A. western-blotting 
assay; B. the ratios of protein densities of treatment groups over the control groups expressed as 
the mean ± SD of the relative expression levels of each protein; measured by NIH Image J; 
*p<0.05; paired t-test).    
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Figure 10. The attachment of S. mutans (UA159) to immobilized saliva.  
0.25 mg/ml of CSC increased the attachment of S. mutans (UA159) to saliva-coated 96-well 
plates by 50.7% (OD values were compared by a paired t-test, *p<0.05). 
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Figure 11. The expression of antigen I/II by S. mutans (UA159) in response to different 
concentrations of CSC.  
A. western-blotting assay; B. the ratios of protein densities of treatment groups over the control 
groups expressed as the mean ± SD of the relative expression levels of each protein; measured by 
Image J; *p<0.05; paired t-test.    
*  
 *  
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Figure 12. The attachment of S. mutans (NG8 and PC3370) to the immobilized saliva.  
The increased bacterial attachment to saliva in response to CSC treatment was through 
upregulation of S. mutans antigen I/II (OD values were compared by a paired t-test). 
a. CSC increased the attachment of NG8 (wild-type strain) to saliva-coated 96-well plates by 
61.0% (*p=0.006).  
b. There was no significant change between treated PC3370 (antigen I/II deficient strain) and 
its control group (p=0.969).  
a *  
b  
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Figure 13. The average acid generation by S. mutans that was incubated with 1% sucrose.  
Data were expressed by the amount of pH reduction compared to untreated bacteria incubated 
without sucrose (p>0.05, student‟s t-test).  
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Figure 14. The raw prevalence of CVD by the number of teeth missing stratified by age among 
U.S. middle-aged adults, BRFSS, 2006.   
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Figure 15. The interaction effect of smoking and the number of teeth removed stratified by age 
groups.  
RRs of CVD according to the interaction variable (interaction variable=the number of teeth 
missing * smoking status) among six age groups of U.S. middle-aged adults, BRFSS, 2006.  
Relative risks were adjusted for gender, race, education, the number of teeth missing, body mass 
index, if the patient has diabetes, and alcohol consumption (the non-smokers with all teeth 
remaining as a reference group). 
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Figure 16. Relative excess risk due to interaction (RERI) between smoking status and the number 
of teeth missing among different age groups of U.S. middle-aged adults, BRFSS, 2006. 
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Figure 17. The attachment of S. mutans (UA159) to sFn by Western-blot.  
S. mutans (UA159) binds to soluble Fn in a Fn dose-dependent manner and CSC increases 
bacterial binding ability.  
Fn (µg/ml)   16              16                  64                  64 
CSC (mg/ml)  0             0.25                  0                  0.25 
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Figure 18. The attachment of S. mutans (UA159) to sFn by ELISA.  
CSC increased the attachment of S. mutans (UA159) to sFn, and the bacterial attachment was 
reduced by heat-treatment (OD values were compared by a paired t-test). 
a. Bacterial binding to sFn was significantly increased by 14% in response to 0.25 mg/ml CSC 
treatment. (*p<0.05). 
b. Heat treatment significantly reduced bacterial binding to sFn for both CSC treated and 
untreated bacteria, when compared to their own un-heat treated (*p<0.05). The dramatic 
reduction was observed between CSC treated groups, which reached about 63%.  
b  * 
b  * 
a  * 
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Figure 19. The expression of surface proteins by S. mutans (UA159) in response to CSC 
treatment.  
(A) western blot; (B) far-western data by blotting membrane of bacterial surface proteins with 
sFn (50 µg/ml).  
There were at least 9 bands detected on membrane B (white arrows), which indicated that 
multiple proteins on the S. mutans surface were involved in sFn attachment. 
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Figure 20. The attachment of S. mutans (UA159) to immobilized Fn by ELISA.  
CSC increased the attachment of S. mutans (UA159) to immobilized Fn by 22.2% (OD values 
were compared by a paired t-test, *p<0.05).  
  * 
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Figure 21. The attachment of S. mutans (UA159) to HUVECs by ELISA. 
CSC increased the attachment of S. mutans (UA159) to HUVECs (OD values were compared by 
a student‟s t-test, *p<0.05. Bacteria and HUVECs were treated with 0.25 mg/ml and 50 µg/ml 
CSC, respectively). 
a. The attachment of UA159 treated with 0.25 mg/ml of CSC to untreated HUVECs was 
significantly increased over 100%, when compared to the control group. 
b. The amount of untreated bacteria attached to the treated HUVECs was increased only 40%.  
c. The amount of treated bacteria attached to the CSC treated HUVECs also increased almost 
92%.   
 a * 
 c * 
 b * 
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Figure 22. The expression of Fn by HUVECs upon exposure to different concentrations of CSC 
by cell immunostaining.  
The blue-fluorescent color indicated the nucleic acid stained by DAPI and the green-fluorescent 
color indicated the Fn reacted with anti-Fn antibodies conjugated with biotin and 
FITC-streptavidin conjugated with secondary antibodies. 
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Figure 23. The attachment of S. mutans (NG8 and PC3370) to sFn by ELISA.  
Antigen I/II plays an important role in S. mutans attachment to sFn. 
a. Both wild-type (NG8) and antigen I/II-deficient (PC3370) strains had enhanced binding 
ability to sFn in response to 0.25 mg/ml CSC treatment (p<0.05). 
b. The untreated antigen I/II-deficient strain had much lower binding ability to sFn than their 
wild-type counterpart. The binding ability reduced about 22% (p<0.05). 
c. Although the antigen I/II-deficient strain increased binding ability to sFn by 24% in response 
to CSC treatment when compared to untreated PC3370, the binding ability was still lower than 
treated NG8 by 13% (p<0.05). 
 b * 
 a * 
 a  c * 
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Figure 24. The attachment of S. mutans (NG8 and PC3370) to immobilized Fn by ELISA.  
Antigen I/II is also important for S. mutans attachment to immobilized Fn 
a. Both wild-type (NG8) and antigen I/II-deficient (PC3370) strains had enhanced binding 
ability to immobilized Fn in response to 0.25 mg/ml CSC treatment (p<0.05, paired t-test). 
b. The untreated PC3370 had only 62.7% of binding ability of untreated NG8 (p<0.05, paired 
t-test). 
c. Although the treated PC3370 had increased binding ability to immobilized Fn when 
compared to untreated group, the binding ability was still lower than treated NG8 by 24.2% 
(p<0.05, paired t-test). 
 a * 
 b * 
 a c * 
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1 2 3 4 5 6 7 8 9 10
aa residue 361-386 803-822 824-843 834-853 925-944 985-1004 1005-1024 1025-1044 1085-1104 1095-1114
1 0.026 0.754 0.275 0.000 0.002 0.000 0.000 0.084 0.000
2 0.013 0.002 0.181 0.398 0.000 0.012 0.540 0.001
3 0.433 0.000 0.001 0.000 0.000 0.043 0.000
4 0.000 0.000 0.000 0.000 0.006 0.000
5 0.598 0.010 0.156 0.044 0.019
6 0.002 0.348 0.000 0.975
7 0.348 0.000 0.975
8 0.002 0.376
9 0.000  
 
b. Amino acid (aa) residue number refer to S. mutans SpaP. 
 
Figure 25. The regions on antigen I/II responsible for binding to sFn. 
a. sFn bound to ten 19-mer peptides of antigen I/II (ELISA). The amount of sFn bound to the 
ten synthesized peptides of antigen I/II). The p values were listed in the table for the comparison 
between each region (one-way ANOVA, LSD test). 
b. Linear structure of antigen I/II with aa residue number from reference (29). 
132 
NG8                                                      PC3370
A
m
o
u
n
t 
o
f 
b
ac
te
ri
a 
at
ta
ch
ed
 t
o
 H
U
V
E
C
 (
O
D
=
4
5
0
 n
m
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
S. mutans control / HUVEC control 
S. mutans treated / HUVEC control 
S. mutans control / HUVEC treated 
S. mutans treated / HUVEC treated 
 
Figure 26. The attachment of S. mutans (NG8 and PC3370) to HUVECs by ELISA.  
Antigen I/II was important for bacterial attachment to HUVECs in the absence of CSC. (Bacteria 
and HUVECs were treated with 0.25 mg/ml and 50 µg/ml CSC, respectively. One-way ANOVA, 
LSD test) 
a. Without CSC treatment for both bacteria and HUVECs, PC3370 had only 52.1% binding 
ability of their counterparts in NG8 group (*p<0.05).  
b. With the CSC treatment for both, the amount of bacteria attached to HUVECs was similar to 
that of NG8 (p>0.05).  
c. No difference was detected for the NG8 attachment to HUVECs with or without treatment, 
p>0.05). 
 a * 
 c   b  
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DISCUSSION 
1. From bedside to bench work-smoking and caries 
1.1 Smoking is an independent risk factor of tooth loss 
In this large cross-sectional study, 8.4% of the subjects were edentulous which was in 
agreement with the estimates from NHANES 1999-2002 (25) and about 2% lower than 
that from NHANES 1988-1991 (142). Besides the reduction in the prevalence of 
edentulism, the percentage of people with all teeth remaining increased from 30.5% in 
1988-1991 (142) to 46.3% in the current analysis. About 18.8% of the subjects were 
current smokers including daily and occasional smokers. This figure was slightly lower 
than the report of 2006 and 2007 National Health Interview Survey (NHIS), which 
estimated approximately 20.8% and 19.8% of U.S. adults were current cigarette smokers, 
respectively (2-3).  
 
It is known that tooth loss is associated with age. The relative risks of smoking for tooth 
loss in the current study increased with aging across the age groups with 5-year increment, 
but they were not in a linear relationship. The association seemed to be more pronounced 
among people between 35 to 64 years. To eliminate the influence of the uncontrolled risk 
factors that caused this discrepancy, we divided the samples into 3 age groups-young 
group (18-34 years), middle-aged group (35-64 years) and elder group (65 years or older). 
The relationship between tooth loss and its risk factors like smoking, BMI and dental 
visits were analyzed for all populations and also stratified for these 3 age groups.  
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In the present study, a significant association between smoking and the prevalence of 
tooth loss was demonstrated among all age groups. A previous epidemiological study in 
Sweden found that 41% of the smokers at age of 75 or older were edentulous, while 
about 35% of non-smokers at the same age had lost all of their teeth (14). We had similar 
findings in which almost 40% of current smokers at age of 65 or older had lost all of their 
teeth. However the prevalence of edentulism among non-smokers was low in the current 
study when compared to the previous Swedish study (16.2% vs 35%). Among the 
youngest group between 18 to 34 years, almost 40% of current daily smokers had lost one 
or more teeth, which was much higher than what was found in a Japanese national survey 
(168). It was reported that 31.4% of Japanese current smokers aged between 20 to 39 
years had one or more teeth removed.  
 
Smokers are likely to have a lower educational level, a negative attitude towards dental 
health such as regular dental examinations and a higher risk of diabetes. All of these 
factors also are associated with tooth extraction. Following the adjustment of these 
confounding factors, the risk for current daily smokers for tooth loss was as high as 3 
times, which was in line with a previous investigation in the Boston area (119). In that 
study, compared with non-smokers, the hazard ratios for tooth loss were 2.4 and 3.5 for 
current male and female smokers, respectively. Moreover, we found that this relationship 
was more pronounced among middle-aged current daily smokers. The RRs of current 
daily smokers to have teeth lost were 2.58, 3.18 and 2.59 for young adults (18-34 years), 
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middle-aged adults (35-64 years) and the elderly (65 or older), respectively. This finding 
might indicate the cumulative effect of smoking on tooth loss for middle-aged smokers 
and other unknown factors associated with tooth loss among the elderly.  
 
Although the BRFSS database did not provide information on exact cigarette 
consumption, the dose-dependent relationship between smoking and tooth loss was 
estimated by the categories of “smoking every day” and “smoking some days”. Our data 
clearly indicated a dose-response relationship regarding cigarette smoking exposure. The 
current occasional smokers had a lower risk of having teeth removed than current daily 
smokers (1.96 vs 2.95). Dietrich et al. reported that among a population of male health 
professionals, the risk for current smokers of 5 to 14 and 45+ cigarettes daily to have 
teeth removed was 1.94 (95% CI, 1.72-2.18) and 3.05 (95% CI, 2.38-3.90), respectively, 
when compared with those that had never smoked (55). 
 
The reports describing the association between the number of teeth lost and former 
smokers have been controversial (77, 120, 231). The difference might depend on the 
sampling methods, such as how long the subjects have stopped smoking. Although the 
deleterious effect on the teeth remaining might be reduced after smoking cessation, it 
would take 10 to 20 years for former smokers to have a similar risk of tooth loss as 
non-smokers (119, 231). For example, former male smokers who quit smoking only for 1 
year were still at risk of tooth extraction with a RR of 2.0 (95% CI, 1.4-2.9), while for 
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those after 15 years of abstinence, the risk reduced to the level of non-smokers with a RR 
of 1.0 (95% CI, 0.5-2.2) (120). In the present study, former smokers still had a 1.6-fold 
risk of tooth extraction when compared to non-smokers. However, the risk was much 
lower for former smokers than for current daily and occasional smokers. Because we do 
not have information as to when these former smokers stopped smoking, the accurate 
impact of smoking cessation on the remaining teeth cannot be established. 
 
The prevalence of edentulism is a significant mark of a population‟s general health and 
the quality of health in a society, because tooth loss might limit the ability to speak, 
decrease masticatory function, cause chewing problems, and affect social interaction and 
communication (71). The goal of the World Health Organization for oral health in 2000 is 
to maintain a natural dentition of not less than 20 teeth throughout life. This number is 
believed to guarantee an individual adequate masticatory efficiency and ability. Tooth 
loss has a negative impact on the quality of life (57). It was further suggested that an 
early intervention before age 50 which targeted oral health improvement might increase 
self-satisfaction throughout life. In the current study, 22.7% of subjects lost at least 6 or 
more teeth (including those edentulous subjects), which indicated that they are likely to 
have impaired masticatory ability and social interactions if they do not receive proper 
prosthodontic treatment.  
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Both caries and periodontal diseases are major contributors to tooth loss. Distinct from 
earlier periods, dental caries or periodontal diseases no longer attack every individual due 
to the widespread use of fluorides, oral hygiene promotion and the use of antibiotics in 
clinical treatments (154). This trend has meant that other risk factors might contribute to 
tooth decay or periodontal diseases, which should be more important for planning public 
health activities.  
 
Besides cigarette smoking, other preventable risk factors for tooth loss have been 
identified. The patterns of visiting a dentist or dental clinic were notably related to tooth 
loss. Generally, people with a regular dental visit each year had less teeth removed than 
those with longer term dental visits. However, the risk for young adults who did not have 
a dental visit for more than 2 years was lower than those who had a visit within 1 to 2 
years. The purposes of a dental visit can be categorized into routine attendance and 
problem-oriented attendance (208). The different associations between tooth loss and 
dental visits among different age groups might be due to the different purposes for 
visiting a dentist or dental clinic. Higher BMI and existing diabetes conditions were risk 
factors for tooth loss and were consistent among all age groups, which was in agreement 
with other findings (172, 205). Physical activity in leisure time and consumption of 
alcohol seemed to be protective factors.  
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Because the data used for the current study were from a national record, our samples 
represent a non-institutionalized U.S. population (aged ≥18 years). The relative risk and 
risk factor prevalence data can be calculated from the same population. Thus, the 
population attributable fractions (PAF) were estimated for all of these preventable risk 
factors and might be used for making future public health decisions. The PAF estimates 
the proportion of the disease of interest in the total population that would not have 
occurred if the risk factor could be eliminated from this population (127). The PAF is 
determined by the prevalence of risk exposure and the magnitude of association and is 
commonly used to evaluate the impact of different risk exposures at the population level. 
Among these risk factors including smoking status, dental visits, BMI and existing 
diabetic condition, PAFs of smoking status were highest because of the higher prevalence 
of smoking exposure and stronger association. Our results indicated that smoking 
significantly contributes to tooth loss.  
 
Although the prevalence of current smokers decreased dramatically from about 43% in 
1960 to 19.8% in 2007 among all sociodemographic subpopulations of adults, the 
declines during the past decade progressed slowly towards the national health objectives 
for 2010 which aim to reduce the prevalence of cigarette smoking among adults to <12% 
(3, 227). In the present study, about 18.8% of surveyed adults in 2006 were current 
smokers. Also, it was estimated that among those with one or more teeth removed, over 
22% was due to current daily smoking. Furthermore, among the middle age group (35-64 
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years) more than 27% of those with more than 1 tooth removed were estimated to have 
lost no or fewer teeth if they had quit smoking. However, for people at age of 65 years or 
older, the most important contributor for tooth loss was irregular dental check-ups. 
Almost 65% of those who lost one or more teeth were due to “not visiting a dental clinic 
for over 5 years”. Our data clearly suggested that maintaining a functional dentition 
throughout life was significantly associated with smoking cessation for all age groups and 
increased oral health care access for the elderly. 
 
This study draws strength from its large sample size and representative subjects in the 
analysis. Although smoking has been linked to tooth loss for a long time and this 
association has been well investigated in Europe and Asia (14, 77, 168), very few studies 
have examined this relationship among a population in the USA (55, 119-120). However, 
the populations of previous studies were not nationally representative samples. In the 
present study, over 314,986 samples with a large age variation were analyzed. These 
participants resided throughout all 50 states, the District of Columbia, Puerto Rico, the 
Virgin Islands, and Guam.  
 
Since tooth loss is the ultimate result of a complex process in which many other factors 
related to tobacco use might be involved, this secondary data analysis was unable to 
collect other factors like diet to control potential confounders. It was reported that 
smokers consumed more sugar containing soft drinks and snacks, and less fruit than 
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non-smokers (14). In this secondary data analysis, we do not have any information about 
the diet and oral hygiene for the subjects, which are also related to tooth loss.  
 
Because the design of BRFSS was cross-sectional, the point in time when the teeth were 
extracted was not available in this analysis. Thus, it was not possible to establish the time 
sequence between smoking status and tooth loss. Although we found a strong association 
between cigarette smoking and tooth loss independent of other risk factors such as age, 
gender, social economic status, the frequency of dental visits, and diabetes etc, we could 
not assume a causal association between smoking and tooth loss. However, the biological 
plausibility could be investigated to further determine the relationship between smoking 
and caries which is one of the major contributors to tooth loss. Therefore, the effect of 
smoking condensate on cariogenic bacteria examined by in vitro studies is discussed 
below. 
 
1.2 The in vitro effect of cigarette smoke condensate on cariogenic bacteria 
Over 700 species of bacteria have been identified in the human oral cavity (4). S. mutans 
is usually observed predominantly in cavitated lesions and S. gordonii is found in 
significant proportions on sound tooth surfaces (141). Therefore, S. mutans has been 
regarded as the primary causative pathogen of dental caries, while S. gordonii, as an early 
plaque colonizer, has been considered a non-cariogenic bacterium (24).   
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To determine the effect of smoking on oral bacteria in vitro, cariogenic and 
non-cariogenic bacteria were compared in this study. To our knowledge, this is the first 
report comparing the effect of CSC on the growth and sucrose-dependent adherence of 
two oral bacterial species. Previously, the effect of nicotine or cotinine on oral bacterial 
growth had been reported. Keene and Jonson (106) reported that higher concentrations of 
nicotine (1.62 and 16.2 mg/ml) completely inhibited the growth of S. mutans, but nicotine 
at lower concentrations around 16.2 to 162.2 µg/ml increased bacterial growth, while the 
lowest concentrations from 16.2 to 162.2 ng/ml reduced growth. But for S. gordonii, 
Streptococcus mitis and Streptococcus oralis, Cogo et al. (38) reported that neither 
nicotine nor cotinine at concentrations ranging from 0.4 to 400 µg/ml reduced nor 
stimulated bacterial growth.  
 
Up to now about 6,000 compounds have been identified in tobacco cigarette smoke (47). 
Whether nicotine is the only or major bioactive component in tobacco against oral 
bacteria previously was unknown. It is reasonable to use tobacco extracts to study 
bacteria in response to different levels of smoking exposure. Since the concentration of 
CSC in saliva is unclear, the concentrations of CSC used in the current study were chosen 
based on the amount of nicotine contained therein. Concentrations of nicotine in saliva 
can be as high as 4,000 ng/ml immediately after smoking (206), or as low as 70 ng/ml 
(185), Therefore, based on the calculation suggested earlier by using the yield of 26.0 mg 
CSC per cigarette provided by the supplying company (162), the highest dose of CSC 
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used in the sucrose-dependence adherence assay (0.25 mg/ml CSC in 10 ml of media) 
was equivalent to only one tenth of a cigarette and contains 6 µg/ml nicotine, which was 
comparable to the salivary nicotine concentration of heavy smokers consuming over 20 
cigarettes per day (174) . 
 
In the current study, it was found that CSC had an antibacterial effect on both S. mutans 
and S. gordonii at high concentrations. Pavia et al. (176) observed that viridians 
streptococci were highly susceptible to nicotine at concentrations over 100 µg/ml. When 
oral streptococci were exposed to eight puffs of smoke from one cigarette for 3 hours, the 
viable bacterial cells of S. mitis, S. salivarius, and S. sanguis had 1 to 2 log10 fold 
decreases between smoke-treated and untreated bacteria (20). Both of these studies 
confirmed our finding that CSC with the same level of nicotine had an antibacterial effect. 
However, the MIC of S. gordonii was significantly lower than that of S. mutans.  S. 
mutans seemed to tolerate higher concentrations of CSC than S. gordonii regarding the 
results of the MIC, MBC and time-kill assays. Although CSC seemed to influence S. 
gordonii less than S. mutans in terms of doubling time when compared to their own 
control groups, the increased doubling time of S. mutans was the same as that of S. 
gordonii when they were treated with 0.25 mg/ml CSC. Moreover, 0.25 mg/ml of CSC 
significantly prolonged the lag phase of S. gordonii, but did not significantly affect that of 
S. mutans. This evidence indicated that S. mutans adapted to the environmental challenge 
of CSC more quickly than S. gordonii.  
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Besides the differential influence of CSC on bacterial viability, this study also found that 
CSC increased bacterial sucrose-dependent adherence for S. mutans, but not S. gordonii. 
When S. mutans cells were treated with 0.125 mg/ml of CSC, the amount of tightly 
adherent bacterial cells on a smooth glass test tube surface was over 40% higher than the 
control group. This result was confirmed by the dextran-binding assays in which it was 
observed that the dextran-binding ability of treated S. mutans was more than twice as 
high as the control group. The sucrose-dependent binding ability of S. gordonii was not 
affected by CSC treatment. The western-blotting results clearly demonstrated that CSC 
up-regulated the expression of several surface proteins such as GTF and Gbps of S. 
mutans, which may explain why S. mutans had increased sucrose-dependent attachment.   
 
Sucrose-dependent adherence, which is mainly regulated by the enzymatic and 
glucan-binding action of glucan-binding proteins, plays a key role in dental plaque 
biofilm formation (19). These enzymes include GTF, GbpA, GbpB, GbpC and GbpD. 
The GTFs are extracellular enzymes, which hydrolyze sucrose into fructose and glucose, 
synthesize glucans from glucose and facilitate bacterial attachment via a glucan-binding 
domain.  GTFs are crucial  dhesion  of S. mutans in the pathogenesis of dental caries. 
The level of caries developed in a gnotobiotic rat model infected with a GTF-deficient S. 
mutans strain was significantly reduced when compared to those infected with the wild 
type of S. mutans (158). Although S. gordornii is believed to be an early colonizer on the 
tooth surfaces in the absence of sucrose, GTF is still important for sucrose-associated 
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accumulation in dental biofilms (220). Therefore, when noncariogenic bacteria like S. 
gordonii compete with cariogenic bacteria such as S. mutans for sucrose in dental plaque, 
the bacteria which have higher quantities of GTF might take the lead in survival and 
attachment. 
 
At least four glucan-binding proteins have been reported for S. mutans (19). In this study, 
we used western blots to assess GbpA and GbpB, both of which were up-regulated in the 
groups with CSC treatment. In the presence of sucrose, GbpA was observed to have an 
important role in biofilm architecture-that is, inactivation of the gbpA gene of S. mutans 
reduced the height of the biofilm (17, 79). Although GbpB was considered essential for 
cell-wall cycling and synthesis (67), the biofilm formed by S. mutans in vitro was still 
positively related to the level of GbpB production (152). Thus, glucan-binding proteins 
make significant contributions to the aggregation of S. mutans and the biofilm 
architecture (79). The current study clearly demonstrates that the enhanced 
sucrose-dependent adherence of S. mutans by CSC was consistent with the increased 
production of glucan-binding proteins like GTF, GbpA and GbpB. The increased 
expression of GTF, GbpA and GbpB by S. mutans in response to CSC indicated that this 
pathogen in the oral cavities of smokers may have better ability to form biofilm and be 
more dominant in dental plaque.  
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Antigen I/II with a molecular weight of 185 kDa, is highly immunogenic and has been 
suggested as an effective vaccine component for caries prevention (126). It is believed 
that antigen I/II is a major determinant for the initial step of bacterial colonization and 
involved in dental caries development. Antigen I/II is essential for bacterial initial 
attachment to tooth surfaces coated with salivary pellicle film, especially for S. mutans 
(114). In the oral cavity, bacterial adhesion to salivary coated surfaces may be influenced 
by environmental conditions. In this study, we demonstrated that wild-type S. mutans 
(UA159 and NG8) treated with smoking condensate had enhanced binding abilities to a 
saliva-coated solid surface. Correspondingly, the production of antigen I/II by S. mutans 
increased in response to the smoking condensate treatment. However, the mutant strain 
(PC3370) adhered to the salivary film less than the parent strain, and CSC treatment did 
not influence the attachment of the mutant strain at all. Our data were consistent with 
previous findings that antigen I/II is required for S. mutans attachment to saliva coated 
surfaces (10, 177). Our data further indicated that antigen I/II is essential for S. mutans 
binding to immobilized salivary film with or without smoking challenge. 
 
It is speculated that the different response to CSC treatment between S. mutans and S. 
gordonii is modulated by a two component system (TCS). TCS, which are typically 
composed of a sensor (histidine kinase) and a response regulator, have been considered as 
signal transduction devices and are engaged in a multitude of gene regulatory systems in 
response to a wide variety of environmental stimulation (23). The signals from 
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environment may cause the autophosphorylation of the histidine kinase, and then a 
response regulator can be phosphorylated by the sensor kinase. At last the phosphoryl 
group will activate the coupled response regulator and leads to changes in gene 
expression. Although S. mutans and S. gordonii share similar functions of key TCS 
components in the adaption of fluctuating environmental conditions, recent research 
found the significant difference in TCS function in the general stress tolerance between 
these two strains (129-130). It is of interest to investigate if TCS also play an important 
role in bacterial adaption to CSC and what are the different functions of TCS between S. 
mutans and S. gordonii.  
 
Despite the specific/non-specific plaque hypothesis for dental caries (132-133), Marsh 
(145) also proposed an ecological plaque hypothesis, which suggested a direct and 
dynamic relationship between the environment and bacteria. The key concept of the 
ecological plaque hypothesis is that the bacterial strains which are able to acquire, 
transport, and catabolize organic compounds under selective pressure will have an 
advantage in adapting to the particular microenvironment. On the other hand, the 
increased ratio of cariogenic bacteria to non-cariogenic bacteria such as S. mutans/S. 
sanguinis was considered a risk factor of caries development among children (224). 
Under the challenge of cigarette smoking, cariogenic S. mutans were observed to tolerate 
higher tobacco concentrations than the noncariogenic S. gordonii, and have greater 
sucrose-dependent attachment by up-regulating some important proteins. Both of these 
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facts are closely related to the virulence of S. mutans and suggest that the microbiological 
profile in the oral cavities of smokers may shift from a non-cariogenic to a cariogenic 
dominant ecology. This may partially explain why smokers are prone to caries 
development. 
 
Tobacco smoking increased colonization of some pathogens like Streptococcus 
 dhesion  and Streptococcus pyogenes in the nasopharynx of smokers (31). Moreover, 
the number of pathogens recovered from the nasopharynx of healthy children exposed to 
environmental smoking was higher than their peers with nonsmoking parents. To date, no 
study was compared the microbial profile of smokers and non-smokers regarding caries, 
except that one study has reported that children exposed to environmental tobacco smoke 
had a higher number of salivary S. mutans than control subjects (13). However, several 
studies were reported a significant difference in the prevalence of subgingival bacteria 
between smokers and nonsmokers with periodontitis (102, 217). In a study which 
compared the microbial profile of smokers and non-smokers with early onset 
periodontitis, it was found that Staphylococcus aureus, Bacteroides forsythus and 
Porphyromonas gingivalis. Were more frequently isolated in higher numbers from 
smokers than nonsmokers, while Streptococcus intermedius, Actinomyces naeslundii, 
Actinomyces israelii and Eubacterium lentum were more often detected in higher 
proportions among nonsmokers (102). The clinical data by van Winkelhoff et al. (217) 
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also indicated smoking as a determining factor for the composition of the subgingival 
microflora in adult patients with periodontitis.  
 
Acid production, in particular low pH in dental plaque, is thought to be an important 
ecological determinant in dental caries. In this study, the acid producing capability of S. 
mutans was not altered significantly between the groups treated with or without smoking 
condensate over a 135-min observation. However, the velocity with which S. mutans 
treated with low concentrations of smoking condensate (0.0625 and 0.125 mg/ml) 
produced acid seemed to exceed that of the control group and bacteria treated with high 
concentrations of CSC after a 30-min incubation of 1% sucrose. The acid production 
further emphasized that S. mutans challenged with smoking condensate maintained their 
capability of acid production so that they might have the ability to generate acid quickly 
if they were treated with lower concentrations.   
 
In summary, we observed that, although the higher concentration of CSC (over 7 mg/ml) 
had antibacterial effects on both cariogenic bacteria like S. mutans and a commensal 
bacterium such as S. gordonii, S. mutans was able to survive better than S. gordonii in the 
same concentrations of CSC, especially at sub-MBC concentrations. Attachment of S. 
mutans to tooth surfaces is the critical step in the formation of dental plaque by this 
organism and is mediated by sucrose-independent and sucrose-dependent mechanisms of 
adherence. In the present study, CSC also enhanced bacterial virulence by increasing the 
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sucrose dependent and-independent attachment of S. mutans. S. mutans expresses a range 
of cell surface  dhesion proteins like GTF, Gbps and antigen I/II which facilitate the 
bacterial formation of dental plaque. The increase in the sucrose-dependent attachment 
was via up-regulation of glucan-binding proteins of S. mutans in response to CSC. The 
increased production of antigen I/II of CSC treated S. mutans was consistent with the 
enhanced S. mutans attachment to immobilized salivary film. Based on these findings, it 
is reasonable to speculate that the better survival ability and improved bacterial adherence 
of S. mutans in an environment full of cigarette smoking components will help them 
thrive and dominate in the complex microbial community of dental biofilm. Moreover, S. 
mutans growing in dental plaque in response to a smoking challenge still retains a similar 
ability to produce acid. Our study may explain, at least partly, why smokers are prone to 
caries development.  
 
However, mixed species cultures were not used in this study. Bacterial species growing 
together within dental plaque may respond to CSC in a different way from a 
mono-species culture. Therefore, future studies should be conducted to study the response 
of S. mutans or other cariogenic bacteria to CSC when cultured with other non-cariogenic 
bacteria. The composition of cariogenic and non-cariogenic bacteria should also be 
compared between smokers and non-smokers in clinical investigations.  
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2. From bedside to bench work-the effect of smoking and oral health status on CVD 
2.1 The joint effect on CVD of smoking and oral health status  
The reason a middle-aged population aged 35 to 59 years was chosen in the current 
analysis was to eliminate the effects of some known and unknown confounding factors 
associated with age, because of the higher prevalence of edentulism and CVD among 
older individuals. In this selected middle-aged population, about 3.9% of people were 
edentulous, while 21.0% of people at 65 years or older were edentulous (see the result 
Part 1). Approximately 6.0% of the subjects had been diagnosed with CVD. This figure 
also was much lower than a previous report which found almost 37.1% of adult men and 
women age 20 or older had some form of CVD (NHANES 1999-04) (183). Also, another 
previous study failed to find a significant association between dental infection and 
coronary heart disease (CHD) in a population aged over 55 years (149). 
 
We also combined “current smoking every day” (current daily smokers), “current 
smoking some days” (current occasional smokers) and “former smokers” into one group 
of “smokers”, because: 1) there is no safe level of smoking for CVD (232); and 2) 
although after one-year of smoking cessation, the risk for CHD decreases by 50% (207), 
it also might take former smokers at least 5 years to reduce the levels of inflammatory 
markers to that of non-smokers (15) and we did not know when the former smokers in the 
2006 BRFSS database quit smoking.  
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It was estimated that almost 90% of CVD cases were caused by nine factors including 
dyslipidaemia, hypertension, smoking, stress, diabetes, obesity (especially abdominal fat 
distribution), physical inactivity, poor diet with insufficient fruit and vegetable intake and 
excessive alcohol consumption (232). The magnitudes of these associations vary in 
different geographic regions, ethnic groups and ages. In the current study, we found that 
smokers were at higher risk of developing CVD with RR around 1.54 (95% CI, 
1.47-1.62). Our finding was in agreement with previous reports that the relative risks for 
smokers for developing a stroke or MI were 1.5 and 1.8, respectively (46, 195). The 
strength of this association was similar among age groups 35-39, 40-44, 45-49, 50-45 and 
55-59. However, it was reported that this association was age-dependent (195, 232). The 
discrepancy was probably because of the different population characters. For example, 
we limited the analysis to people between 35 to 59 years and the age varied from 45 to 84 
years old in the previous studies. Besides smoking, we consistently found that other risk 
factors such as existing cases of diabetes, higher BMI and physical inactivity were 
significantly associated with the prevalence of CVD. However, we found that heavy 
drinkers defined in 2006 BRFSS had lower risk of developing CVD. The reason of the 
discrepancy might be due to the different definitions used in the different surveys.  
 
As for the oral health status, we confirmed that novel risk factors, less teeth remaining 
and irregular dental check-ups, were also significantly associated with CVD. The number 
of teeth removed was significantly associated with CVD prevalence in a dose-dependent 
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manner and the adjusted RRs for people with 1-5, 6 or more and all teeth removed were 
1.37 (95% CI, 1.29-1.45), 2.19 (95% CI, 2.04-2.34) and 2.79 (95% CI, 2.55-3.04), 
respectively. In a previous study, which also analyzed BRFSS data from 1999 to 2002 to 
examine the association between tooth loss and heart disease, the dose-response 
relationship between missing teeth and heart diseases remained significant after 
adjustment for all other risk factors (170). The OR for people with 1-5 missing teeth was 
1.22 (95% CI, 1.02-1.45), which was similar to our result, and the ORs for people with 6 
or more missing teeth and being edentulous were 1.64 (95% CI, 1.34-2.20) and 1.87 
(95% CI, 1.50-2.33), respectively, which were lower than what we observed. The 
difference between the current and previous analysis might be due to: 1) the outcome of 
the previous study only consisted of cases of myocardial infarction and angina, while we 
included both stroke and heart diseases in the outcome variable; and 2) the previous study 
analyzed a population aged 40 to 79 years, and the current study was limited to 
middle-aged adults aged 35 to 59. Furthermore, regular dental visits identified as a 
protective factor of CVD indicated that effective dental treatment helps control the total 
burden of dental infection and reduce the risk of CVD caused by poor oral health status. 
 
Moreover, the association observed was age-dependent which was attenuated with aging, 
especially for the subjects with all teeth removed. Okoro et al. (170) also reported that the 
ORs of the edentulous was 3.21 (95% CI, 2.25-4.59) and 1.71 (95% CI, 1.31-2.23) 
among people aged 40-59 and 60-79, respectively. Dietrich et al. (54) indicated that the 
153 
association between periodontal disease/edentulism and CHD decreased continuously 
with increasing age, and might approach null for people at about 60 to 65 years.  
 
It is implied that, if the individual has multiple risk factors, these risk factors might 
interact with each other and produce a greater risk than what would be expected from 
adding the independent risks together (32, 233). This trend has been driven by 
highlighting the importance of effective interventions to reduce the morbidity and 
mortality of CVD patients with multiple risk factors. The risk factors of smoking status 
and tooth loss have been explored individually in many studies (52, 68, 170, 221) and 
confirmed in our secondary analysis of 2006 BRFSS. Furthermore, we did find a 
combined effect of smoking status and the number of teeth removed among this 
middle-aged American population. To our knowledge, this is the first report concerning 
the joint effect of tooth loss and smoking on CVD.  
 
Two observations supported this claim. First, the assessment of the interaction was 
performed by simply introducing the product term (smoking status * the number of teeth 
missing) into the logistic risk model. It has been argued that the interaction expressed by 
a product term on a multiplicative scale only presents the statistical interaction other than 
causal interaction, which is defined as a deviation from additivity of the absolute effects 
(risk differences) of the two risk factors under study (44). Secondly, we applied relative 
excess risk due to interaction (RERI) and attributable proportion (AP) to measure the 
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causal interaction between tooth loss and smoking on CVD. The interaction effect was 
statistically significant for all subjects as well as for all age groups. For example, relative 
to non-smokers with all teeth remaining, the risk of CVD was 1.6 for smokers with all 
teeth remaining, 3.2 for non-smokers with all teeth removed and 5.0 for smokers with all 
teeth removed. These results suggested a more than additive interaction between these 
two risk factors (RERI=1.8; AP=0.19). Therefore, smoking and dental infection may 
modify each other and synergistically increase the risk of CVD by the interaction of 
different biological mechanisms involved in CVD development.  
 
Both dental infection and smoking exposure are closely associated with systemic 
inflammation and modification of the lipid profile of the subjects, which are critical 
components in the initiation and evolution of atherosclerosis (12, 48). Besides these 
effects on atherogenesis, cigarette smoking also could impair vasodilatory function (12) 
and dental infection is able to induce an autoimmune response (64-65). Furthermore, 
smoking exposure also makes dental infections worsen. As mentioned before, 80% of 
total periodontal diseases were attributable to current or former smoking (210). Also oral 
bacteria might gain access to the bloodstream from oral niches though the defective 
periodontal tissue in periodontitis patients more so than in people with healthy 
periodontal tissue (173). It is hypothesized that smokers might have a higher microbial 
load through impaired periodontal tissue, which in turn would increase the possibility of 
endothelial infection. Additionally, our in vitro study (discussed in Part 4) also 
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demonstrated that smoking would enhance bacterial binding to fibronectin and 
endothelial cells, which ultimately may cause endothelial infection.   
 
Moreover, both models demonstrated that the interaction effect was more pronounced 
among younger age groups (between 35 to 44) than older age groups (between 45 to 59), 
especially for the edentulous. One alternative explanation could be uncontrolled, 
age-dependent confounding factors, particularly life-style alterations and accumulating 
toxin inside an elderly body. These risk factors might increase the risk of tooth loss as 
well as CVD. Although complete tooth loss is a marker of previous dental infection and 
demonstrated the highest risk of CVD among those within the same age group, tooth loss, 
especially edentulism, might reduce or eliminate the exposure to dental infection. It was 
assumed that elderly people had their teeth removed for a longer time than younger 
people. Therefore, the inflammatory response caused by dental infections decreased 
among elderly people, which ultimately reduces the risk of CVD. We found that the 
combined effect of missing all teeth and smoking contributed to at least 47% of CVD 
among the youngest adults aged between 35 to 39 years. Our data indicated that younger 
smokers with all teeth removed are at a strikingly higher risk of having CVD and should 
be a major target for CVD prevention. Effective prevention of CVD should be based on 
knowledge of the importance of risk factors for the disease in different subgroups such as 
age and gender.  
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One weakness of this analysis was that we did not have dietary information for this 
population. It was reported that edentulous people consume fewer vegetables, fiber and 
carotene, and more cholesterol, saturated fat and calories than people with 25 or more 
teeth (100). This diet change would increase the risk of CVD. But, we did not have 
dietary information for this population and could not estimate the effect of dietary change 
on CVD among people with more teeth missing. However, since a previous study 
reported that diet was only a small mediator of this association (99), we do not think lack 
of dietary information affects our results significantly. Also, as mentioned in the 
discussion Part 1, because of the cross-sectional design of the BRFSS, it was unable to 
establish a causal association of the joint effect of smoking and tooth loss on CVD. 
However, the biological plausibility had been investigated and is discussed below.  
 
One of the challenges of discovering more effective strategies to preventing the known 
risk factors is to understand these factors from the view point of biological mechanisms. 
In theory, cigarette smoking may not only induce physiological changes and/or impair 
immune function of the host, but also be able to enhance the virulence of pathogens (61). 
To further understand the combined effect of smoking and oral health status that we 
detected in this epidemiological analysis, we conducted an in vitro study to examine the 
effect of smoking condensate on bacterial attachment to Fns and HUVECs, which is the 
critical step for oral bacterial infection beyond the oral cavity.  
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2.2 The effect of smoke condensate on bacterial attachment to fibronectins and 
HUVECs 
Approximate 60% of the total bacteria from early dental plaque are oral streptococci 
(167). S. mutans is a common microbial inhabitant of the oral cavity, and has been 
frequently observed in atheromatous plaque specimens or isolated from the blood of IE 
patients. To be consistent with our previous study of the effect of smoking condensate on 
the virulence factors of S. mutans related to caries, we continued to investigate if smoking 
condensate was also able to enhance the attachment of S. mutans to fibronectin and 
HUVECs, which is believed to be the critical step in causing cardiovascular damage.  
 
Our data demonstrated that smoking condensate significantly increased S. mutans 
attachment to HUVECs and fibronectin in both soluble and immobilized forms. The far 
western and ELISA data documented that S. mutans utilized several different cell surface 
proteins to bind to Fn and HUVECs. One of the most important adhesins identified was 
antigen I/II. However, antigen I/II played different roles in bacterial attachment to Fn and 
HUVECs in response to smoking condensate treatment.  
 
Our far western data demonstrated that there were at least 9 proteins responsible for 
bacterial binding to sFn. Proteins with molecular weights around 180 kDa, 130 kDa, 90 
kDa and 60 kDa corresponded to the molecular weights of antigen I/II, FnBP-130, AtlA 
isoform and FnBP-63, which were able to bind to Fn (36, 101, 155). But, it is still unclear 
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if these proteins are just what had been detected before and what the other 5 proteins are. 
Neither is it known if all 9 of these proteins also contribute to bacterial attachment to 
HUVECs. It was confirmed that S. mutans expresses multiple Fn-binding proteins. The 
ability to utilize multiple adhesins in recognizing Fn could provide a selective advantage 
for S. mutans in the attachment and colonization to host tissue. The heat-treatment assays 
also suggested that bacterial surface proteins are important for bacterial attachment to Fn, 
or at least, the adhesins interacting with Fn were heat-sensitive.  
 
Additionally, the ELISA assays documented the role of antigen I/II in bacterial 
attachment to Fn and HUVECs. It was found that the untreated antigen I/II deficient 
strain (PC3370) had about 78% and 63% of binding ability of its parent strain (NG8) to 
soluble and immobilized Fn, respectively, while the untreated PC3370 only had half the 
binding ability of NG8 to HUVECs. Obviously, in the absence of smoking, antigen I/II 
seemed to be less important for bacterial attachment to Fn than HUVECs, because 
multiple adhesins were responsible for bacterial attachment to Fn. It is also speculated 
that antigen I/II, as one of the important adhesins, is responsible for the interaction with 
multiple receptors on the surface of endothelial cells by a non-selective way due to the 
“soft” structure of antigen I/II (107).  
 
Moreover, not only antigen I/II but also other multiple adhesins were upregulated in 
response to CSC treatment. This could explain, at least in part, why with CSC treatment 
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the antigen I/II deficient strain also had enhanced binding ability to Fn. Since soluble Fn 
is everywhere in body fluids such as saliva and plasma, it is reasonable to believe that S. 
mutans will be coated with Fn before or during dissemination via the bloodstream. The 
increased bacterial binding ability to Fn has significant clinical relevance. First, sFn 
adsorbed on the bacterial surface might help S. mutans escape from immune surveillance 
and migrate from the oral cavity to distant regions of the body (101). Thus, smoking 
exposure might enhance bacterial survival in the bloodstream. Secondly, bacteria coated 
with Fn may attach to host tissues indirectly via Fn-integrin, Fn-fibrin, Fn-collagen, or 
Fn-Fn interactions (76). The bacteria exposed to smoking may have additional binding 
capacity to sFn, which indirectly increases the chance for bacteria to attach and colonize 
on host tissue like heart valves and endothelium with exposed ECM. It is also 
hypothesized that Fn-binding proteins expressed on the bacterial surface would not be 
saturated by sFn in body fluids (36). Therefore, S. mutans exposed to CSC might still 
have unsaturated and upregualted multiple adhesins for the direct attachment to 
immobilized Fn. Overall, the enhanced bacterial binding ability and survival would 
increase the opportunities of bacterial infection outside the oral cavity.  
 
As we found that antigen I/II contributed to almost 50% of bacterial binding to HUVECs 
without CSC treatment, it was of interest to determine whether antigen I/II was still 
important for bacterial attachment to HUVECs in the presence of tobacco. We observed 
that antigen I/II was an essential adhesin for bacteria to adhere to saliva coated surfaces 
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with or without tobacco treatment (in the result of Part 2). Also, antigen I/II was still 
important for bacterial adherence to Fn with CSC exposure because the binding ability of 
treated PC3370 to Fn was significantly lower than that of treated NG8. Without tobacco 
exposure, we found that antigen I/II plays a significant role in mediating adhesion of S. 
mutans to HUVECs. A previous study also found that antigen I/II played an important 
role in the interactions between bacteria and endothelial cells through lectin interactions 
(219). However, in response to smoking condensate treatment of both bacteria and 
HUVECs, the amount of treated mutant strain bacteria attached to the treated HUVECs 
was similar to that of its parent strain. This finding suggests that, in the presence of 
smoking condensate for both bacteria and HUVECs, antigen I/II is a redundant adhesin 
for S. mutans attachment to HUVECs, because the multiple adhesins expressed by 
PC3370 might be upregulated and make up the antigen I/II deficiency in the antigen I/II 
mutant strain. These data also support the concept that the bacterial attachment to any 
single ECM component does not necessarily mean that bacteria have the same trend to 
adhere to host cells.  
 
Furthermore, it was also interesting to find that more treated S. mutans UA159 bound to 
untreated HUVECs than untreated UA159, while there was no significant difference 
between the treated S. mutans NG8 and untreated NG8. Previously it was observed that 
NG8 had the fibrillar fuzzy layer on the surface, which was associated with the 
expression of antigen I/II or some types of adhesins (126). Therefore, it was hypothesized 
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that UA159 and NG8 might produce different amounts of adhesins, which would be 
upregulated by both strains in response to CSC treatment. However, the increased 
adhesins of treated NG8 might be redundant because the untreated NG8 already produces 
enough adhesins for all receptors expressed by treated or untreated endothelial cells. The 
increased adhesins produced by treated UA159 should be an advantage for bacterial 
attachment to HUVECs, because untreated UA159 had less fuzzy coat and expressed less 
adhesins without CSC stimulation.  
 
Additionally, the cell surface-associated Fn expressed by HUVECs was upregulated in 
response to CSC treatment as illustrated in the immunocytochemistry experiments. These 
in vitro results were consistent with a previous clinical finding, which observed that 
current or past cigarette smoking history were independently associated with an increase 
in circulating cFn (104). Also the increased Fn was associated with the development of 
atherosclerotic plaques (26). The increased production of Fn might also provide more 
binding sites for bacterial attachment and/or foundation for additional ECMs like 
collagen and laminin, which may ultimately build up endothelial basal lamina and narrow 
the vessels. 
 
Little is known about the molecular mechanisms of the increased expression of Fn by 
endothelial cells. A previous study found that nicotine was able to induce the expression 
of Fn in cultured lung fibroblasts (182). It was also suggested that nicotine induction of 
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Fn is dependent on the activity of protein kinases, mitogen-activated protein kinases and 
on the activation and DNA binding by CREB, an important modulator of fibronectin gene 
transcription. Furthermore, these regulations were induced by the activation of specific 
nicotinic receptor-α7 nAChR. It is of interest to investigate the molecular mechanisms of 
Fn production by endothelial cells in response to CSC.  
 
However, the increased Fn on the cell surface observed in the current study might also be 
caused by less degradation of Fn in response to CSC treatment. It has been observed that 
endothelial cells are able to produce matrix metalloproteinase-2 (123), MMP7 (88), 
MMP9 (88), MMP10 (166), MMP12 (88) , MMP14 (123), MMP16 (123), MMP19 (116) 
and MMP26 (92), many of which are able to degrade Fn (37, 87). Moreover, cigarette 
smoke exposure was found to inhibit the activity of extracellular MMP-2 (gelatinase A) 
in human lung fibroblasts (121), decrease MMP-9 levels in asthmatic basolateral 
secretions (225). However, until now it is unclear if tobacco smoking affects the MMPs 
expressed by endothelial cells. It is reasonable to hypothesize that cigarette smoke 
condensate might also be able to decrease the MMPs expression by endothelial cells 
and/or inhibit the activity of MMP expressed by endothelial cells.    
 
To further investigate which regions were responsible for the bacterial attachment to sFn, 
we did some preliminary experiments using shorter derivatives of antigen I/II from the 
A-region to the C-terminal region. We found that the ability of residues 1005-1044 and 
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1095-1144 binding to sFn was higher than others. Therefore, the C-terminal region 
contains a major binding site for sFn. Previous data also demonstrated that four peptides, 
1005-1024, 1025-1044, 1085-1104 and 1095-1114 inhibited S. mutans binding to salivary 
receptors (109). However, it is difficult to rule out the potential influence of structural 
change resulting from the intact antigen I/II amino acid sequence, because these 19-mer 
peptides had short linear sequences. Generally, the structural organization of each peptide 
is regarded as a feature allowing interactions of the adhesin with a number of receptors 
on target cells or extracellular matrix constituents (107). The tertiary or quaternary 
folding of the whole amino acid sequences may bring these separated residues together. 
That is, the binding sites may be far apart on the amino acid sequence but actually may be 
closely related spatially. Therefore, the structural organization may allow the adhesin to 
interact with a number of receptors on target cells or extracellular matrix constituents. 
 
Overall, our data suggested that antigen I/II possesses an important role in bacterial 
attachment to Fn and HUVECs, which could be considered as an opportunistic virulence 
factor associated with the pathogenesis of inflammatory disorders. However in the 
presence of smoking condensate, other mechanisms of attachment may be invoked 
because of multiple adhesins on the bacterial surface and multiple receptors on host cells. 
As demonstrated in our immunostaining data, CSC stimulated HUVECs to produce more 
Fn. Therefore, smoking may not only increase bacterial adhesin expression, but also 
cause tissue damage to express more ECM macromolecules such as Fn. Our work 
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stresses the importance of toxicity of smoking from the view point of both host and 
pathogen responses. Collectively, our findings may explain, at least in part, the combined 
effect of smoking and oral health status that we found in the epidemiological data 
analysis.   
 
In summary, our data clearly demonstrates that: 1) smoking condensate enhanced 
bacterial attachment to Fn and HUVECs; 2) antigen I/II is essential for bacterial 
attachment to both soluble and immobilized Fn regardless of CSC treatment or not; and 3) 
antigen I/II is required for S. mutans attachment to HUVECs in the absence of CSC, but 
redundant bacterial attachment in the presence of CSC. The different roles of antigen I/II 
attachment to Fn and HUVECs between smokers and non-smokers may help in 
developing different preventive or therapeutic strategies against attachment and 
colonization of the host by S. mutans.  
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CONCLUSIONS 
In summary, we investigated the effect of cigarette smoking on the virulence of 
Streptococcus mutans on caries and cardiovascular disease via epidemiological analysis 
and in vitro studies. Based on the results and discussions presented above, it can be 
concluded that: 
1) Smoking is an independent risk factor of tooth loss in a dose-dependent manner. 
Smoking cessation might reduce the risk of tooth loss.  
2) Cigarette smoking condensate at higher concentrations has antibacterial effects on 
both cariogenic bacteria-S. mutans and commensal bacteria-S. gordonii. However, S. 
mutans is able to tolerate higher concentrations of CSC than S. gordonii.  
3) In response to CSC treatment, S. mutans has enhanced sucrose independent, and 
dependent-adherence and retains the similar acid production capability to that of 
untreated bacteria.  
4) The number of teeth lost is associated with CVD prevalence in a dose-dependent 
manner. Furthermore, regular dental check-ups are a protective factor for CVD.  
5) Smoking status and tooth loss have a joint effect on CVD development, especially 
among a younger age group.  
6) CSC significantly increases S. mutans binding to sFn, immobilized Fn and HUVECs.  
7) Antigen I/II is important for bacterial attachment to Fn and salivary coated surfaces 
with or without CSC exposure.  
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8) Antigen I/II is more important for bacterial attachment to HUVECs in the absence of 
CSC treatment than in the presence of CSC treatment.  
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